Human body chip operating system
Through the biochip operating system, the human chip board and multiple biochip arrays are used to solve the problems of waste of resources and low data collection efficiency in cell culture experiments, and accurate drug testing and efficient data collection under physiological conditions are realized, supporting real-time Multiplexing measurements enhance the predictive power of drug development.
Patent Information
- Application Number
- CN202280092409.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2021-12-23
- Filing Date
- 2022-12-23
- Publication Date
- 2024-11-26
AI Technical Summary
Existing cell culture experiments are difficult to accurately simulate physiological conditions, resulting in high failure rate during drug development, and low resource waste and data collection efficiency. Especially in complex 3D cell culture models, the operating system cannot realize real-time multiplexing measurements. and efficient fluid management.
A biochip operating system was designed to realize cell growth, culture medium pumping and real-time measurement through a human chip plate and an array of multiple biochips, using ultra-thin porous catheters and microfluidic channels, combined with valve system and automated control. Supports the integration of a variety of analytical technologies, including microscopy, spectroscopy and FTIR, for accurate drug testing.
The system realizes precise cell culture and drug testing under physiological conditions, reduces resource waste, improves data collection efficiency and standardization and repeatability of experiments, supports real-time multiplexing measurements, and enhances the prediction capabilities of drug development .
Smart Images

Figure 00000036_0000 
Figure 00000037_0000 
Figure 00000038_0000
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims priority to and the benefit of U.S. Provisional Patent Application No. 63 / 293,422, filed on December 23, 2021, the entire contents of which are incorporated herein by reference.
[0003] background
[0004] Developing successful drugs is expensive and time consuming. In addition, many drugs fail in the late stages of the development process, resulting in huge sunk costs. One reason why drugs fail in the late stages of development is that pharmaceutical companies often test drugs on cells grown on cell culture platforms, which do not adequately replicate human tissue. 3D organ-on-chip technology has emerged to create more similar tissue models and solve structural and 3D tissue assembly problems. However, the operating system still has the problem of how to replicate the mechanics and fluid dynamics of the operating system's advanced 3D models while feeding, maintaining and growing tissues and measuring and analyzing target parameters in real time in the operating system's advanced system.
[0005] Current cell culture experiments often fail to accurately mimic physiological conditions because they use simple methods that do not reproduce the entire system but only a few aspects. In developing and operating 3D advanced cell culture models, multiple factors go hand in hand. The operating system factors span various design parameters, including the complexity of the model, the connection mechanism between different organ models, the pumping, seeding and sampling mechanisms, and also the measurement, sensing and imaging mechanisms, followed by analytical and predictive technologies. A holistic system spanning all the later factors is needed to obtain accurate drug predictions from preclinical testing.
[0006] A major persistent problem faced by current tissue culture semi-automatic operation systems is the need for large quantities, tens of milliliters of material, which is wasted because only a few microliters of cells and biological materials are used for inoculation. This limits tissue culture and modeling using expensive or scarce materials (such as biopsy tissue).
[0007] Another important aspect of the operation of complex 3D culture models is analytical readout, which limits high-throughput analysis as well as real-time data collection. In addition, in current organ chips, it is challenging to frequently access cells and / or culture medium samples for analysis at different time points. Culture medium is defined as any fluid containing any of the following substances: therapeutic agents, growth factors, nutrients, chemicals, suspended cells and / or any other molecules, biomolecules or substances flowing through the channel.
[0008] Typical complex 3D cell culture platforms cannot image or measure biological parameters of separate tissues connected to a human-on-chip model in real time while manipulating the culture medium and flowing it into the biochip. One of the limitations is the real situation in the design that prevents one or more analytical devices from being placed near the chip. For example, in order to be able to simulate the metastasis of cancer from one tissue to another through the 3D vasculature, two tissues cannot be imaged simultaneously while pumping fluid through the blood vessels. Similarly, in most cases, much of the valuable data generated is limited to a few data points, rather than continuous measurements.
[0009] A fundamental aspect of typical chip designs and the connection methods used between organs is the inability to set up complex experiments with multiple organs while maintaining accurate sensing and communication. These systems lack the communication and sensing found in the human body and the ability to set up any experiment in a chip format.
[0010] One major limitation these systems face when sampling and injecting media is the need for high volumes of fluid to compensate for the volume of the tubes in the system. The use of ultra-thin tubes or microchannels prevents the need to have a dilution factor, which is used in other systems to move fluids. However, such low diameter tubes maintain high capillary forces and higher surface tension within the tubes, where low volumes of fluid can be transferred to another destination. In addition, the absence of a dilution factor ensures that the sample is highly concentrated in the molecules we need to detect, resulting in more accurate measurements and results.
[0011] A fundamental aspect of cell culture experiments is the ability to accurately measure and read physiologically relevant data. Microscopy, spectroscopy, and FTIR are some of the widely used techniques for quantitative measurements of biological materials that indicate cell viability, function, and metabolism. Most human chip operating systems currently found on the market rely on external measuring devices to perform such assays. These tests will require the operator to stop the experiment and transfer it to the measuring device. This will result in the loss of valuable observations and data between set time points. Performing such manipulations will increase the number of variables, which may have unplanned effects on the experimental results. There is an urgent need to achieve multiplexed real-time measurements on running cell culture experiments. For example, the implementation of an onboard triple measuring system consisting of microscopy, spectroscopy, and ATR-FTIR tightly integrated with the operating system will provide more valuable information and better experimental representations, while eliminating any variables that may be formed due to repositioning of the culture. The importance of having multiple measurement techniques to perform various readings while connected to the same data reader is that it allows multiplexed analysis and conclusions that would not otherwise be possible.
[0012] Overview
[0013] The present disclosure provides a new and innovative biochip operating system, which serves as a cell culture platform for modeling and operating multiple human organs at the same time. The operating system includes a human chip board and operates on the human chip board, and the human chip board is an array of multiple biochips connected together by duct fluids simulating multiple organs of the human body. Cells can be injected into the biochip and grow into three-dimensional tissues for drug testing. Each biochip can include one or more ultra-thin porous plastic cylindrical ducts. Each duct can enter from the inside or from the area around the duct through a microfluidic channel.
[0014] Due to biochips, the present disclosure provides a means of replicating a ductal organoid microenvironment, which is achieved by growing ductal cells on the inner wall of each duct, and by inoculating cells from the other side around the duct and growing surrounding tissues from the outside through gel delivery of culture medium components, thereby replicating the ductal organoid microenvironment. Each biochip can be used to replicate ductal or non-ductal tissues, including but not limited to: pancreas, kidney, liver, breast, brain, lung, vascular system, prostate, fallopian tube, testis and lymphatic vessels. The human chip board is an array of biochips, each of which grows specific tissues and simulates specific tissues, and is connected to other biochips through one or more duct fluids of each biochip. The biochip ducts are separated by a valve system (valving system) that allows connections between different biochips. These biochips can be connected in series, in parallel or in combination. In addition, the valve system allows these connections to be changed at any point. The chip can also be connected to a sampling chamber, ATR-FTIR or waste chamber.
[0015] The present disclosure provides a biochip operating system, which is a semi-automatic or fully automatic device that operates on a human chip board to pump and control the flow of fluids containing cell growth medium, chemicals and cells into each channel of the biochip. The human operating system also includes sensing and measuring equipment to measure and control different biological parameters of tissues grown inside the biochip. The actuation of fluid valves and pumps and sensors and images is fed into computer software that automates the cell culture and measurement processes. The biochip operating system can be used by, but is not limited to, researchers, pharmaceutical companies and clinicians to test their drugs or other ingredients on a complete human model made of cells, primary cells, stem cells and / or cell lines from biopsy tissue. The system can perform, control and measure a wide range of whole cell culture experiments.
[0016] The present disclosure provides a system including apparatus and methods for pumping and controlling very small volumes (as low as 0.1 μl) of fluid containing cells, culture media, therapeutic agents, chemicals, reagents and other biological components into each channel inside each individual biochip. The present disclosure allows accurate, repeatable and reproducible biological experiments to be performed on highly similar tissue models.
[0017] In another aspect of the present disclosure that may be used in combination with any other aspect or combination of aspects listed herein, a biochip operating system includes at least one biological system on a chip board, at least one valve device, at least one actuator for actuating the valve device, at least one fluid handling device, at least one analytical device; and a control system for controlling a pumping device, an actuator device and a valve device and an analytical device.
[0018] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, the analysis device may utilize at least one of microscopic images or spectroscopic measurements to examine the biochip.
[0019] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, an analytical apparatus can examine culture medium in a fluid handling device or fluid path.
[0020] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, an operating system facilitates, semi-automates, or automates at least one aspect of an experimental setup, including at least one of: cleaning, sterilizing, or preparing the system; perfusing the system with a biocompatible fluid; filling the chip with the correct cell type in the correct location required for the desired experiment; selectively connecting the chip in the correct arrangement for the desired experiment; and / or metering the correct amount of culture medium or other compound into the system.
[0021] In another aspect of the present disclosure that may be used in combination with any other aspect or combination of aspects listed herein, an operating system facilitates, semi-automates, or automates at least one aspect of experimental execution, including at least one of: circulating culture medium between chips as required by the experiment; controlling the flow rate of fluid movement; extracting samples, possibly at specific times or time intervals; inspecting using an analytical device at specific times or time intervals and / or separating and fixing the biochip for subsequent analysis.
[0022] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, the operating system further comprises a motion stage for moving the biological system on the chip board relative to the analysis device and / or the actuation device.
[0023] In another aspect of the present disclosure that may be used in combination with any other aspect or combination of aspects listed herein, a biochip for multi-conduit tissue growth comprises a chassis, a plurality of interior regions, wherein the base comprises a plurality of interior regions, wherein at least one interior region is in permeable or semi-permeable communication with at least one other interior region and a plurality of fluid culture media.
[0024] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, the plurality of interior regions are tubular conduits.
[0025] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, at least two tubular conduits are arranged with an inlet and an outlet to allow a first fluid culture medium to flow therethrough.
[0026] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, at least two tubular conduits are arranged with inlets and outlets different from the inlet and outlet of the first conduit to allow a second fluid culture medium that may be different from the first fluid culture medium to flow therethrough.
[0027] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, at least one region is a stromal compartment outside the conduit but inside the biochip base.
[0028] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, the plurality of fluid culture media are the same culture media.
[0029] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, the plurality of fluid culture media are different culture media.
[0030] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, the plurality of fluid culture media is a combination of fluid culture media types.
[0031] In another aspect of the present disclosure that may be used in combination with any other aspect or combination of aspects listed herein, the biochip fluid control includes at least one human chip, the human chip including at least one organ chip system, wherein the at least one organ chip system includes at least one catheter support docked with at least one surrounding compartment, at least one valve system for controlling flow to each compartment, at least one micropump mechanism that can pump and control flow to at least one compartment, at least one actuator for controlling valves on the chip and leading to the chip, and at least one actuator for controlling fluid pumped to the chip compartment, wherein at least one valve system can open or close the flow path to each compartment and can convert the flow path to each compartment.
[0032] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism can be at least one of pneumatically actuated, mechanically actuated, electrically actuated, and fluidly actuated.
[0033] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism connects at least one biochip to an operating system.
[0034] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism connects at least two biochips in a human chip connection plate.
[0035] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism controls at least two biochips in a human body chip connection plate.
[0036] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism controls at least one inlet and outlet biochip.
[0037] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism connects at least one conduit to another conduit and controls the connection between the at least one conduit and the other conduit.
[0038] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism connects at least one stroma to another stroma.
[0039] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism connects at least one conduit to at least one substrate and controls connection between the at least one conduit and the at least one substrate.
[0040] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism connects at least one biochip to at least one measuring device.
[0041] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism includes at least one bistable valve.
[0042] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism includes at least one open close valve.
[0043] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism includes at least one bistable valve and at least one on-off valve.
[0044] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, at least one bistable valve maintains a state position by a beam, a magnet, or any drilled hole geometry.
[0045] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein,
[0046] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, at least one on-off valve maintains a state position by the geometry of the bore.
[0047] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism controls medium injection in at least one biochip.
[0048] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism controls cell injection in at least one biochip.
[0049] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, at least one valve mechanism maintains cell culture by medium injection.
[0050] In another aspect of the present disclosure that may be used in combination with any other aspect or combination of aspects listed herein, a human body chip plate comprises: at least one 3D culture biochip, at least one microvalve, at least one microfluidic channel, at least one inlet or outlet plate port, wherein the outlet port from one chip can be connected to another chip by laying out valves, wherein multiple chips can be connected in parallel, in series, or in combination, and one or more chips in the human body chip plate can be bypassed, wherein each fluid connection can be changed independently and at any time, wherein at least one valve system connects or separates different compartments of an organ chip system and different compartments between organ chip systems, wherein at least one inlet and one outlet port are used to enter and block a microchannel, wherein at least one valve system can allow sampling, change of model flow diagrams, and introduction or reduction of at least one fluid chamber, wherein valves that can be controlled in a bistable position by actuators and sensors are all positioned at the channel ports of the chip, wherein the valves are positioned adjacent to the chip and can be controlled in a bistable position.
[0051] In another aspect of the present disclosure that may be used in combination with any other aspect or combination of aspects listed herein, a human chip plate comprises at least one organ chip system comprising at least one catheter support docked with at least one surrounding compartment, wherein at least one organ chip system comprises at least one catheter support docked with at least one surrounding compartment.
[0052] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, plates may be quickly connected from the bottom or side where fluids are to be exchanged.
[0053] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, the human chip plates are interchangeable wherein ports on the human chip will align with fittings in the biochip and valves are fixed or removable.
[0054] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, a human body chip board includes interconnected built-in chips.
[0055] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, the valve is fixed or removable.
[0056] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, a human body chip allows access to fluids from the top or side.
[0057] In another aspect of the present disclosure that may be used in combination with any other aspect or combination of aspects listed herein, a multiplexed logic microvalve system includes a plurality of microvalves, at least one fluid path comprising at least one channel, inlet and outlet ports, at least one bistable mechanism, at least one actuation mechanism, at least one structure encapsulating other elements of the microvalve, wherein the fluid path has no dead volume, wherein multiplexing between the plurality of valves reduces the amount of actuation input, and wherein the valves can control the fluid within the channel so that the flow can be hydrostatic or kinematic.
[0058] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, at least one logic multi-way microvalve is used to control a fluid in a system.
[0059] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, a valve can direct a sample to at least one sampling port.
[0060] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, the bistable mechanism may be a bistable beam on the flexible pipe valve.
[0061] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, a fluid pathway may connect at least one biochip to multiple components within a human chip system.
[0062] In another aspect of the present disclosure which may be used in combination with any other aspect or combination of aspects listed herein, a bistable valve has two stable positions.
[0063] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, at least one channel comprises a pneumatically actuated balloon.
[0064] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, the system may require power only when switching between the two states and once actuated, the bistable beam will remain in place.
[0065] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, the microvalve may be a bistable magnetic drilled-piston valve.
[0066] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, the bistable mechanism may include a magnetic channel.
[0067] In another aspect of the present disclosure, which may be used in combination with any other aspect or combination of aspects listed herein, the bistable beam of the microvalve may be electromagnetically actuated or pneumatically actuated.
[0068] In summary, the human operating system is a self-enclosed system in which multiple cell types can grow and connect to each other, and experiments can be run automatically within the system. The purpose of this system is to be used for tissue modeling and drug testing in order to better predict the effects of diseases, biological parameters, and drugs before testing them on humans. This allows standardization of cell culture conditions to ensure that physiological conditions reach unprecedented levels. This also ensures that real-time and endpoint experiments are performed within the system. The system disclosed herein allows an integrated approach to ensure standardization, reproducibility, accuracy, speed, and cost reduction. BRIEF DESCRIPTION OF THE DRAWINGS
[0070] Some example apparatus embodiments of the present disclosure and example processes for making and using one or more example embodiments are described herein in detail and by way of example with reference to the accompanying drawings (which are not necessarily drawn to scale with respect to any internal or external structures shown) and in which like reference numerals designate like elements throughout the several views and in which:
[0071] 1 shows a schematic diagram of two conduits (labeled I and IV) surrounded by a matrix (III) and included in a base (II) according to an example of the present disclosure.
[0072] FIG. 2A shows a schematic diagram of an embodiment of a 2-conduit 1-matrix biochip according to an example of the present disclosure.
[0073] 2B shows a schematic top view of an embodiment of a 2-conduit 1-matrix biochip according to examples of the present disclosure.
[0074] FIG. 2C shows a schematic diagram of the manufacturing and assembly process of a 2-channel 1-substrate chip according to an example of the present disclosure.
[0075] 3A shows a schematic diagram of another embodiment of a 2-conduit 1-substrate chip with three parallel channels according to examples of the present disclosure.
[0076] 3B shows an exploded view of a 2-conduit 1-matrix chip with three parallel channels according to examples of the present disclosure.
[0077] 3C shows a schematic diagram of the fabrication and assembly process of an embodiment of a 2-conduit 1-substrate chip with three parallel channels according to an example of the present disclosure.
[0078] 4A shows a schematic diagram of another embodiment of a 2-conduit 1-substrate chip having three parallel channels with a substrate supply channel according to examples of the present disclosure.
[0079] 4B shows detailed schematic top and bottom views of a 2-conduit 1 -substrate chip having three parallel channels with a substrate supply channel according to an example of the present disclosure.
[0080] 4C shows an exploded view of an embodiment of a 2-conduit 1 -substrate chip having three parallel channels with a substrate supply channel according to an example of the present disclosure.
[0081] 4D shows a schematic diagram of the manufacturing and assembly process of a 2-conduit 1-substrate chip with three parallel channels having a substrate supply channel according to an example of the present disclosure.
[0082] 5A shows a schematic diagram of a 2-conduit 1-substrate chip with different substrate inlets according to an example of the present disclosure.
[0083] 5B shows a schematic top view of another embodiment of a 2-conduit 1-substrate chip with different substrate inlets according to examples of the present disclosure.
[0084] 5C shows an exploded view of a 2-conduit 1-substrate chip with different substrate inlets according to examples of the present disclosure.
[0085] 5D shows a schematic diagram of the manufacturing and assembly process of a 2-conduit 1-substrate chip with different substrate inlets according to an example of the present disclosure.
[0086] 6A shows a schematic diagram of a 2-conduit 1-substrate chip with multiple substrates per conduit according to an example of the present disclosure.
[0087] 6B shows an exploded view of a 2-conduit 1-substrate chip with multiple substrates per conduit according to an example of the present disclosure.
[0088] 6C shows a schematic diagram of the manufacturing and assembly process of a 2-conduit 1-substrate chip with multiple substrates per conduit according to an example of the present disclosure.
[0089] FIG. 7A shows a schematic diagram of an embodiment of a human biochip plate according to an example of the present disclosure.
[0090] 7B shows a schematic diagram of individual biochip components of a human chip board according to an example of the present disclosure.
[0091] FIG. 7C shows an exploded view of a human chip board according to an example of the present disclosure.
[0092] 8A shows a schematic diagram of an embodiment of a human body chip according to an example of the present disclosure, wherein the individual chip entities are incorporated into a base as 1 part, and the valve mechanism connecting the individual chip components is a cylindrical rotating mechanism.
[0093] 8B shows a schematic diagram of an entity of an embodiment of a human body chip according to an example of the present disclosure, wherein the individual chip entities are combined in a base as 1 part, and the valve mechanism connecting the individual chip components is a cylindrical rotating mechanism.
[0094] 8C shows an exploded view of an embodiment of a human body chip according to an example of the present disclosure, wherein the individual chip entities are incorporated into the base as 1 part, and the valve mechanism connecting the individual chip components is a cylindrical rotating mechanism.
[0095] 9A shows a schematic diagram of an example human chip embodiment according to the present disclosure, wherein the individual chip entities are incorporated as one part within a base, and the valve mechanism connecting the individual chip components is a pneumatically actuated flexible membrane mechanism (isometric view).
[0096] 9B shows a schematic diagram of another embodiment of a human body chip according to an example of the present disclosure, wherein the individual chip entities are incorporated into the base as 1 part, and the valve mechanism connecting the individual chip components is a pneumatically actuated flexible membrane mechanism (top view).
[0097] 9C shows a schematic diagram of another embodiment of a human body chip according to an example of the present disclosure, wherein the individual chip entities are incorporated into the base as 1 part, and the valve mechanism connecting the individual chip components is a pneumatically actuated flexible membrane mechanism (top view).
[0098] Figure 9D shows a schematic diagram of an embodiment of the lower base feature of another embodiment of the human body chip according to the example of the present disclosure, wherein the separate chip entities are combined in the base as 1 part, and the valve mechanism connecting the separate chip components is a pneumatically actuated flexible membrane mechanism (top view).
[0099] 10A shows a schematic diagram of an embodiment of a top view of an embodiment of a HOC plate with the OOC removable from the HOC plate and fluid entering from the side, according to an example of the present disclosure.
[0100] 10B shows a schematic diagram of an embodiment of an exploded view of an embodiment of a HOC plate according to an example of the present disclosure, wherein the OOC is removable from the HOC plate and fluid enters from the side.
[0101] 10C shows a schematic diagram of an embodiment of intra-plate channels of an embodiment of a HOC plate according to an example of the present disclosure, wherein the OOC is removable from the HOC plate and fluid enters from the side.
[0102] 11 shows a schematic diagram of an embodiment of a top view of an embodiment of a HOC plate from which the OOC may be removed and fluids and cells sampled in situ, according to an example of the present disclosure.
[0103] 12 shows a schematic diagram of an embodiment of a top view of an embodiment of a HOC plate from which the OOC can be removed and fluids and cells sampled through channels, chambers, and valves according to an example of the present disclosure.
[0104] 13 shows a schematic diagram of an embodiment of intra-plate channels of an embodiment of a HOC plate according to an example of the present disclosure, wherein two conduit chips are connected to a 1-conduit biochip.
[0105] Figure 14 shows a schematic diagram of including pressure sensors at each chip inlet and outlet fluid ports to manipulate the pressure within the chip channels. This allows fluid to be controllably perfused from the conduit channels to the matrix channels or from the matrix channels to the conduit channels, according to examples of the present disclosure.
[0106] 15A shows a perspective view of a hydraulic valve mechanism connecting separate biochips according to an example of the present disclosure.
[0107] 15B shows a perspective view of a cylindrical rolling valve mechanism connecting separate biochips according to an example of the present disclosure.
[0108] 15C shows a perspective view of a flexible membrane valve mechanism connecting separate biochips according to an example of the present disclosure.
[0109] 15D shows a perspective view of a chip-connected microvalve assembly process according to an example of the present disclosure.
[0110] 16A illustrates a perspective view of a direction-changing flow microvalve plate actuator according to an example of the present disclosure.
[0111] 16B shows a detailed view of a direction-changing flow microvalve plate actuator according to an example of the present disclosure.
[0112] 16C shows a perspective view of a solenoid magnet on-off microvalve according to an example of the present disclosure.
[0113] 16D shows a detailed view of a solenoid magnet on-off microvalve according to an example of the present disclosure.
[0114] 16E shows a perspective view of a solenoid magnet opening and closing a microvalve plate according to an example of the present disclosure.
[0115] 16F shows a detailed view of a solenoid magnet inlet-outlet microvalve actuator plate according to an example of the present disclosure.
[0116] 17A illustrates a perspective view of a normally closed pneumatically actuated on-off membrane microvalve according to an example of the present disclosure.
[0117] 17B shows an exploded view of a normally closed pneumatically actuated on-off membrane microvalve according to an example of the present disclosure.
[0118] 17C illustrates a perspective view of an additional embodiment of a normally open, pneumatically actuated on-off membrane microvalve according to examples of the present disclosure.
[0119] 17D shows an exploded view of an additional embodiment of a normally open, pneumatically actuated on-off membrane microvalve according to examples of the present disclosure.
[0120] 18A shows a perspective view of a pneumatically actuated bistable beam on a flexible tube microvalve according to an example of the present disclosure.
[0121] 18B shows an exploded view of a pneumatically actuated bistable beam on a flexible tube microvalve according to an example of the present disclosure.
[0122] 19A shows a perspective view of a bistable magnetic drilled piston microvalve according to an example of the present disclosure.
[0123] 19B shows an exploded view of an embodiment of a bistable magnetic drilled piston microvalve according to examples of the present disclosure.
[0124] 20A shows a perspective view of a bistable mechanically actuated flexible tube microvalve according to an example of the present disclosure.
[0125] 20B illustrates a top view of an embodiment of a bistable mechanically actuated flexible tube microvalve according to examples of the present disclosure, with one bistable beam in a closed position.
[0126] 20C shows a cross-sectional view of a bistable mechanically actuated flexible tube microvalve in an open position according to an example of the present disclosure.
[0127] 20D illustrates a cross-sectional view of a bistable mechanically actuated flexible tube microvalve in a closed position according to an example of the present disclosure.
[0128] 21A shows a perspective view of a mechanically actuated ball-shaped on-off microvalve according to an example of the present disclosure.
[0129] 21B shows a close up perspective view of an embodiment of a mechanically actuated ball-shaped on-off microvalve (the chip is moving and the screwdriver is moving) according to an example of the present disclosure.
[0130] 21C shows a detailed view of a socket engaging a microvalve to switch between an open position and a closed position according to an example of the present disclosure.
[0131] 21D shows a cross-section of a detailed view of a mechanically actuated ball-shaped on-off microvalve according to an example of the present disclosure.
[0132] 22A shows a cross-sectional view of a permanently sealed on-off microvalve in its closed position according to an example of the present disclosure.
[0133] 22B shows a side view of a permanently sealed on-off microvalve in its preset closed position with a pin tightly inserted into the channel to block the channel according to an example of the present disclosure.
[0134] 22C shows a cross-sectional view of a permanently sealed on-off microvalve in its preset open position according to an example of the present disclosure.
[0135] 22D shows a side view of a permanently sealed on-off microvalve in its open position, with the pin not tightly inserted into the channel, according to an example of the present disclosure.
[0136] FIG. 23A illustrates a perspective view of an embodiment of an assembled operating system according to examples of the present disclosure.
[0137] 23B illustrates a perspective view of an embodiment of an assembled operating system major components according to an example of the present disclosure.
[0138] 23C illustrates a perspective view of a top view of an embodiment of assembled operating system fluid components according to examples of the present disclosure.
[0139] 23D illustrates a perspective view of an embodiment of an assembled operating system with a mixing chamber drawer open, according to examples of the present disclosure.
[0140] FIG23E shows an exploded view of an embodiment of an operating system according to examples of the present disclosure.
[0141] 23F shows a side view of an embodiment of an operating system pressure driven pumping for assembly of a microchamber according to an example of the present disclosure.
[0142] 23G illustrates a bottom perspective view of an embodiment of an assembled operating system pressure driven pumping for a microchamber according to an example of the present disclosure.
[0143] 23H illustrates a bottom perspective view of an embodiment of an assembled operating system pressure driven pumping for a microchamber according to an example of the present disclosure.
[0144] 231 illustrates a bottom perspective view of an embodiment of an assembled operating system pressure driven pumping for a microchamber according to an example of the present disclosure.
[0145] 23J illustrates a bottom perspective view of an embodiment of an assembled operating system pressure driven pumping for a microchamber, according to an example of the present disclosure.
[0146] Figure 23K shows a perspective view of an embodiment of an assembled operating system flow chart according to examples of the present disclosure.
[0147] 23L shows a flow diagram of a 1 to 72 dispenser that connects a mixing chamber with a culture medium chamber connected to a human chip board, according to an example of the present disclosure.
[0148] FIG. 24 shows a flow chart of another embodiment of an assembled operating system according to examples of the present disclosure.
[0149] 25A illustrates a perspective view of another embodiment of an operating system cover according to examples of the present disclosure.
[0150] 25B illustrates an exploded view of an operating system cover according to an example of the present disclosure.
[0151] FIG. 25C shows a perspective view of the human body chip insertion process inside an operating system according to an example of the present disclosure.
[0152] 25D illustrates a perspective view of a spectroscopic probe and sensing board inserted into an operating system according to an example of the present disclosure.
[0153] FIG. 25E shows an exploded view of all operating system components according to an example of the present disclosure.
[0154] 25F illustrates a perspective view of a fluid control portion of an operating system according to an example of the present disclosure.
[0155] 26A illustrates a perspective view of an embodiment of a pneumatic valve actuation operating system according to an example of the present disclosure.
[0156] 26B illustrates an exploded view of a pneumatic valve actuation operating system according to an example of the present disclosure.
[0157] 26C illustrates a top view of a pneumatic valve actuation operating system according to an example of the present disclosure.
[0158] Figure 27A shows an embodiment of components of a culture medium chamber of another embodiment of a human chip, wherein the individual chip entities are incorporated into the base as 1 part, and the valve mechanism connecting the individual chip components is a pneumatically actuated flexible membrane mechanism (isometric view).
[0159] Figure 27B shows the exploded assembly of the culture medium chamber of another embodiment of the human body chip, in which the individual chip entities are integrated into the base as 1 part, and the valve mechanism connecting the individual chip components is a pneumatically actuated flexible membrane mechanism (isometric view).
[0160] 27C shows a perspective view of a culture medium chamber plate according to an example of the present disclosure.
[0161] 27D shows an exploded view of a culture medium chamber plate according to an example of the present disclosure.
[0162] 27E shows a perspective view of a piston plate according to an example of the present disclosure.
[0163] 27F illustrates a perspective view of an additional embodiment of a piston plate according to examples of the present disclosure.
[0164] 27G illustrates a side view of an embodiment of a piston plate according to examples of the present disclosure.
[0165] 27H shows a detailed view of a single piston of FIGS. 27E-27G , according to an example of the present disclosure.
[0166] 271 illustrates a top perspective view of a piston actuator plate according to an example of the present disclosure.
[0167] 27J illustrates a bottom perspective view of a piston actuator plate according to an example of the present disclosure.
[0168] 27K illustrates a perspective view of a fluid source culture plate according to an example of the present disclosure.
[0169] FIG28A shows a flow chart of a process of operating a human body chip system according to an example of the present disclosure.
[0170] FIG28B shows a flow chart of a culture medium chamber filling process of a human chip operating system according to an example of the present disclosure.
[0171] 28C shows a flow chart of the culture medium chamber emptying process of a human chip operating system according to an example of the present disclosure.
[0172] 28D shows a flow chart of the culture medium chamber inoculation process of a human chip operating system according to an example of the present disclosure.
[0173] FIG28E shows a flow chart of a culture medium sample collection process of a human chip operating system according to an example of the present disclosure.
[0174] FIG28F shows a flow chart of a cell sample collection process of a human chip operating system according to an example of the present disclosure.
[0175] 29A shows a flow chart of fluid control in a triple measurement mechanism according to an example of the present disclosure.
[0176] 29B shows a logic control diagram for fluid control for FTIR sampling according to an example of the present disclosure.
[0177] 30A shows a flow chart for pumping a sample from a culture medium chamber to a biochip according to an example of the present disclosure.
[0178] FIG. 30B shows a flow chart for pumping a sample from a biochip to a measurement device according to an example of the present disclosure.
[0179] 31A shows a flow chart for pumping gel into a matrix channel according to an example of the present disclosure.
[0180] 31B shows a flow chart for pumping gel out of a matrix channel according to an example of the present disclosure.
[0181] 32A shows a schematic diagram of a fully assembled embodiment of a mixing chamber according to examples of the present disclosure.
[0182] FIG. 32B shows a schematic diagram of an embodiment of a cell source mixing chamber according to examples of the present disclosure.
[0183] 32C shows a schematic diagram of an embodiment of a culture medium source mixing chamber according to examples of the present disclosure.
[0184] 32D shows a schematic diagram of a side-by-side cell chamber and a medium chamber according to an example of the present disclosure.
[0185] 32E shows a flow diagram of an embodiment of a bubble filter and pressure sensor for a mixing chamber according to an example of the present disclosure.
[0186] 33A shows a flow diagram of an embodiment of a mixing chamber according to an example of the present disclosure, wherein all 36 tubes exit the mixing system.
[0187] 33B shows a perspective view of an embodiment of a mixing chamber according to an example of the present disclosure where all 36 tubes feed into only three tubes exiting the mixing system.
[0188] 33C shows a flow diagram of an embodiment of a mixing chamber according to an example of the present disclosure, wherein all 36 gas tubes are connected to the cell chamber.
[0189] 33D shows a flow diagram of an embodiment of a mixing chamber according to an example of the present disclosure, wherein all three pressure valves are connected to the cell chamber.
[0190] Figure 33E shows a flow chart of an example embodiment of a mixing chamber according to the present disclosure, wherein each row of cell chambers is connected to a 1 / 12 way valve that can switch between them and transfer samples through a flow sensor, air filter, and pressure gauge connected to a quick connector that connects the mixing chamber to a human chip board.
[0191] Figure 33F shows a flow chart of a single cell chamber entity according to an example of the present disclosure, wherein the single cell chamber entity is connected to pressure and gas from one side and to a 1 / 12 way valve from the other side, and the 1 / 12 way valve is connected in the middle to a sensor, air filter and pressure gauge connected to a quick connector, and the quick connector connects the mixing chamber to the human chip board.
[0192] 33G shows a flow diagram of an embodiment of a mixing chamber according to an example of the present disclosure, wherein all 12 tubes are connected to the culture medium chamber.
[0193] 33H shows a flow diagram of an embodiment of a mixing chamber according to an example of the present disclosure, wherein all three pressure valves are connected to the culture medium chamber.
[0194] Figure 33I shows a flow chart of an example embodiment of a mixing chamber according to the present disclosure, wherein each row of culture medium chambers is connected to a 1 / 4-way valve that can switch between culture medium chambers and transfer samples through a flow sensor, air filter, and pressure gauge connected to a quick connector that connects the mixing chamber to a human chip board.
[0195] Figure 33J shows a flow chart of a single culture medium chamber entity according to an example of the present disclosure, wherein the single culture medium chamber entity is connected to pressure and gas from one side and to a 1 / 4 way valve from the other side, and the 1 / 4 way valve is connected in the middle to a sensor, air filter and pressure gauge connected to a quick connector, and the quick connector connects the mixing chamber to the human chip board.
[0196] 34A shows a flow diagram of an embodiment of a mixing chamber according to an example of the present disclosure, wherein all containers have access to O2, CO2 and N2 bottles, O2 and CO2 sensors located below the cell chamber.
[0197] 34B shows a diagram of an embodiment of an O2 and CO2 sensor at the tissue level grown in a chip according to an example of the present disclosure.
[0198] 35A shows an exploded view of a heat exchange plate passing a temperature control fluid in contact with a human body chip according to an example of the present disclosure.
[0199] 35B shows a schematic diagram of a heat exchange generator chamber for heating and cooling fluid to a heat exchange plate according to an example of the present disclosure.
[0200] 36A illustrates a flow diagram of an embodiment of a machine activation mechanism that enables fluid to flow into a system while ensuring that no passages are blocked or any valves, actuators, or sensors are damaged, according to an example of the present disclosure.
[0201] 36B illustrates a flow diagram of an embodiment of a machine activation mechanism that provides temperature, O2, and CO2 levels to a target valve when the flush system is pre-cell seeding, actuator, or sensor is damaged, according to an example of the present disclosure.
[0202] 36C shows a flow chart of an embodiment of a machine start mechanism according to an example of the present disclosure that uses a pressure sensor and with the assistance of microscope computer vision to ensure that there are no bubbles in the system prior to cell seeding (pressurizing all fluids, imaging, light contrast, fluorescence).
[0203] 36D shows a flow chart of an embodiment of a machine that starts using thermal imaging to detect and observe fluid flow, non-wetted surfaces, and bubbles (flash thermal imaging) according to an example of the present disclosure.
[0204] 36E shows a flow chart of an embodiment of a machine start-up and operation mechanism according to an example of the present disclosure, which shows temperature, O2, CO2 and pressure sensors as well as fluid channels, CO2 and O2 mixing, air bubble traps and heating plates that control all parameters of the system.
[0205] 37A shows a perspective view of an embodiment of a microscope and spectroscopy mechanism according to an example of the present disclosure, wherein there is more than one lens.
[0206] 37B shows a perspective view of an embodiment of a microscope and spectroscopy mechanism according to an example of the present disclosure, wherein there is one lens moving in the xy plane.
[0207] 37C shows a perspective view of an embodiment of an FTIR reading mechanism according to an example of the present disclosure, wherein multiple sensors are present.
[0208] 37D shows a perspective view of an embodiment of an FTIR reading mechanism according to an example of the present disclosure, wherein only one sensor is present and the fluid is sampled and measured at calculated time intervals.
[0209] 37E shows a perspective view of a detailed sampling mechanism of an embodiment of an FTIR reading mechanism according to an example of the present disclosure, where only one sensor is present and the fluid is sampled and measured at calculated time intervals.
[0210] 37F shows a perspective view of an embodiment of an FTIR reading mechanism according to an example of the present disclosure, wherein there is a flow cell built into the chip.
[0211] FIG. 38A shows a top view of a possible biochip arrangement for human chip modeling according to an example of the present disclosure.
[0212] 38B shows a perspective view of a possible biochip arrangement for human chip modeling according to an example of the present disclosure.
[0213] 38C shows a top view of an additional embodiment of a possible biochip arrangement for human chip modeling according to examples of the present disclosure.
[0214] Figure 38D shows a perspective view of an additional embodiment of a possible biochip arrangement for cell tissue modeling according to an example of the present disclosure. Briefly, a conduit channel (II) containing endothelial or epithelial cells connects one biochip (I) to at least another biochip (III).
[0215] Figure 39A shows a cross-sectional view of an embodiment of a tubular architecture of tissue in our 2-duct chip according to an example of the present disclosure, wherein I. is the stomatal channel of the biochip; II. is the extracellular matrix, III. is the endothelial and / or epithelial cells that may also contain cancer cells, IV. is the duct channel with culture medium, and V. is the matrix channel with cells that may contain cancer cells.
[0216] 39B shows a perspective view of an embodiment of multiple cultured tissues in our chip connected to a common conduit / vessel according to an example of the present disclosure.
[0217] Figure 39C shows a schematic diagram of an embodiment of an organ chip grown in a human chip according to an example of the present disclosure. The cells can be primary cells, cell lines, IPSCs, patient-derived cells, or biopsy cells, and can be used for precision medicine analysis or for more general analysis. I. is the stomatal channel of the biochip; II. is the extracellular matrix, III. is the tissue or tumor cell of interest, IV. is an immune cell, V. is an endothelial and / or epithelial cell, and VI. is the ductal channel of the biochip.
[0218] Figure 39D shows a schematic diagram of an embodiment of a liquid-air interface lung chip grown in a human chip according to an example of the present disclosure. Wherein, I. is the stomatal channel of the biochip; II. is the extracellular matrix, III. represents endothelial cells, IV. is the duct channel containing air of the biochip, V. represents lung tissue, VI. is respiratory cells, and VI. is astrocytes.
[0219] Figure 39E shows a schematic diagram of an embodiment of a glioblastoma model and a blood-brain barrier in a biochip according to an example of the present disclosure, wherein I. is the stomatal channel of the biochip; II. is the extracellular matrix, III. represents glioblastoma cells infiltrated with immune cells, IV. is immune cells, V. is endothelial cells and pericytes, VI. is the ductal channel of the biochip and VI. is astrocytes.
[0220] Detailed Description of Example Embodiments
[0221] The present disclosure provides five aspects of a system for achieving precise and repeatable semi-automated precision and predictive experiments. The provided experiments enable precise creation and maintenance of tissue models, drug testing, real-time sampling and measurement, and software-assisted control and data analysis. The provided system enables more accurate prediction of drug toxicity, efficacy, and dosage, and is a powerful tool for personalized and precise drug prediction.
[0222] The first aspect of the present disclosure provides a biomimetic tissue culture platform that implements the basic aspects of a biomimetic model. The provided biochip embeds a plurality of cylindrical porous conduit scaffolds that form different compartments in the biochip.
[0223] A second aspect of the present disclosure provides a hybrid human chip tissue culture platform for a human model, wherein the platform can be used alone and with the help of an operating system.
[0224] A third aspect of the present disclosure provides a valving and pumping semi-automatic fluid control system in which very small volumes can be manipulated and controlled in any manner to move samples through all areas of the system, as well as to allow samples to enter and leave the system.
[0225] A fourth aspect of the present disclosure provides a semi-automatic sample collection and real-time measurement add-on component, wherein the configuration of the system allows docking of microscopes, spectroscopy, Fourier transform infrared (FTIR) and other measurement equipment to measure each sample as the experiment is conducted and pumped in and out of the system.
[0226] A fifth aspect of the present disclosure provides software for automating and controlling an operating system, wherein the software includes different commands for different experimental settings. In addition, the software is connected to a measuring device and allows data collection of the measuring device and fluid control mechanism acting on the system.
[0227] Multi-channel biochip
[0228] In an embodiment, the biochip includes at least two conduits and a matrix, and the conduit is formed by a cylindrical ultrathin porous membrane that does not need to be bent. In a further embodiment, the conduit can be made of gore flexible tubing, or the conduit can be made of any material and hole produced by laser spraying or by extrusion. In an embodiment, the biochip can include multiple conduits and multiple matrixes. In addition, a solution different from the solution through multiple conduits can be injected into the matrix. In a further embodiment, known materials (such as stents) can be used in multiple biochips.
[0229] In embodiments, separate membranes for hydrophobicity and hydrophilicity may be used to create the plurality of conduits. In further embodiments, one of the plurality of conduits may be formed from a single membrane having different regions treated to be hydrophobic or hydrophilic by plasma or UV treatment or by coating. Depending on the specific requirements of the user of the system, the hydrophobic and hydrophilic properties of the plurality of conduits may be adjusted according to known processing techniques.
[0230] In an embodiment, a biochip may include multiple chambers to allow for culturing multiple organs on a single multi-conduit biochip.
[0231] In embodiments, a biochip with a single duct may also be utilized by the system of the present disclosure. For example, in embodiments, the biochip used may be a biochip described in PCT Application No. PCT / QA2021 / 050016, entitled “DUCT ORGANOID-ON-CHIP,” filed on June 25, 2021, which is assigned to the assignee of the present invention and is hereby incorporated by reference in its entirety, and which describes a biomimetic tissue culture platform or biochip that implements basic aspects of a biomimetic model.
[0232] FIG. 1 shows a schematic diagram of two conduits surrounded by a matrix according to an example of the present disclosure.
[0233] 2A shows a perspective view of a 2-conduit, 1-matrix biochip according to an example of the present disclosure. In an embodiment, the base of the biochip is constructed of a material that does not obstruct optical or spectral access to the multiple conduits.
[0234] Fig. 2B shows a top view of another embodiment of a 2-conduit, 1-matrix biochip according to an example of the present disclosure. In an embodiment, the biochip may include two porous cylindrical conduit channels surrounded by the same matrix chamber and an air filtration area for each conduit, and the air filtration area may allow bubbles to be released from the biochip. In some examples, the air filtration area may also allow air to enter the biochip, which allows cultured cells to approach the air. In some examples, the biochip may include an inlet and an outlet on each conduit, and for the matrix channel, an inlet and an outlet may be included. The biochip may also include a plurality of pipe segments surrounded by plastic. In an example, the biochip includes a cover glass on the uppermost part of the biochip to cover at least a portion of the top surface of the upper base of the biochip. The upper cover glass may be a thin cover glass made of a brittle, transparent material (such as glass or polymer) with low autofluorescence. The upper base and the lower base include a feature that when placed in direct contact with each other, an internal space is formed to accommodate a porous conduit support made of a film. These features may be the result of engraving in the inner layer of the base. In another example, the upper and lower bases include features that form microfluidic channels leading to external compartments of the catheter support, and the features can be engraved on the outer surface of the base and covered with another base portion or a thin cover glass, thereby forming a complete channel on the lower base to accommodate multiple porous membrane structures.
[0235] In an embodiment, the upper base and the lower base include features that hold the cylindrical conduit support in place, thereby providing access to the internal compartment and external compartment of each conduit support. The base and the microfluidic channel forming the internal compartment leading to the conduit support can extend beyond the entrance hole and the exit hole of the channel, and later plugged with a plug after the biochip is assembled. A bottom cover glass similar to the upper cover glass can be provided to cover the bottommost part of the lower base. In an example, the cover glass glass forming the top and bottom layers of the chip is bonded to the base using a glass polymer glue. In an example, the porous membrane structure is formed by bending the porous membrane into a 180° rotation to form a cylindrical structure, and bonding (bonding) the access material (access material) of the membrane that is not bent into a cylindrical structure. For example, two pre-bonded cylindrical hydrophobic ultra-thin porous membranes on each conduit can be used for filtration. These components can be combined to form a plurality of porous membrane conduit structures surrounded by the same matrix.
[0236] Fig. 2C shows the flow chart of the manufacture and assembly process of 2-conduit, 1-matrix biochip according to the example of the present disclosure.When bending and applying tension on the film at the same time when combined, the porous membrane is bent in a cylindrical manner, approximately oriented at 180 °.In an example, the biochip configured according to the method can include an air filtration area, a conduit surrounded by a matrix, a conduit inlet, a conduit outlet, a matrix channel inlet and a matrix channel outlet.Fig. 2C shows the steps and processes of the bonding process of the biochip components performed according to the method, wherein the conduit support is bent, tensioned and bonded to the base at its end in one step.For example, the method includes the process of positioning and bending a hydrophobic film and a hydrophilic film on the base on the rod, and using glue, heating or chemical methods, the film is bonded to the base at its end.After positioning the film on the base, bending these films on two rods that will form each of the two conduits, applying tension on the film, and bonding the end of the film to the base, the pin is assembled in the outlet matrix hole of the lower base.Then, everything is sandwiched between the two bases, and then chemically assisted hot pressing is used to combine them. Finally, the method may involve a rod and pin removal process, plugging the ends of the two conduit channels beyond the inlet and outlet holes, and assembling cover slip glasses on both surfaces of the biochip.
[0237] Fig. 3A shows a perspective view of an embodiment of a 2-conduit, 1-matrix biochip according to an example of the present disclosure. In an embodiment, the biochip may include two porous cylindrical conduit channels surrounded by the same matrix chamber with a matrix supply channel, and the top conduit may be used to inject gel into the matrix chamber.
[0238] Fig. 3 B shows a perspective view of an additional embodiment of a 2-conduit, 1-matrix biochip with a matrix supply channel according to an example of the present disclosure. In an embodiment, the biochip may include two porous cylindrical conduit channels surrounded by the same matrix chamber with a matrix supply channel, wherein the matrix supply channel is a perforated tube that allows direct supply to the matrix, and the wide hole in the tube increases the diffusion rate between the conduit and the matrix.
[0239] Fig. 3 C shows the flow chart of the manufacture and assembly process of 2-conduit, 1-matrix biochip with three parallel channels according to the example of the present disclosure.Upper base and lower base comprise three parallel channels, and this channel is held in place by two cylindrical conduit supports and perforated pipe and a matrix inlet, thereby provides the way of the internal compartment and the external compartment entering each conduit support.In an embodiment, perforated pipe is glued in the middle channel at its end, and conduit is formed by ultra-thin porous membrane, and ultra-thin porous membrane is bent in cylindrical mode around rod, and glue, heating or chemical method are used to be bonded to base at its end, and pin is assembled in the outlet matrix hole of lower base.Then, everything is sandwiched between two bases, then chemical auxiliary hot pressing is used to combine them.Finally, the method can relate to rod and pin removal process, block the end of two conduit channels beyond inlet hole and outlet hole, and assemble cover glass glass on two surfaces of biochip.
[0240] Fig. 4A shows another perspective view of a 2-conduit, 1-matrix biochip with three parallel channels according to an example of the present disclosure. In an embodiment, two conduits with porous membranes are surrounded by a matrix, wherein the upper middle conduit is connected to the matrix chamber, wherein the two conduits can be used for supply.
[0241] Fig. 4B shows a perspective view of a 2-duct, 1-matrix biochip with three parallel channels according to an example of the present disclosure. In an embodiment, two ducts with porous membranes are surrounded by a matrix, wherein two types of endothelial cells can be cultured in the ducts and one type of epithelial cells can be cultured in the matrix.
[0242] Fig. 4 C shows a perspective view of an additional embodiment of a 2-conduit, 1-matrix biochip with three parallel channels according to an example of the present disclosure, wherein the three parallel channels have a matrix supply channel. In an embodiment, the biochip may include two porous cylindrical conduit channels surrounded by the same matrix chamber with a matrix supply channel, wherein the matrix supply channel is a perforated tube that allows direct supply to the matrix, and the wide hole in the tube increases the diffusion rate between the conduit and the matrix.
[0243] Fig. 4 D shows the flow chart of the manufacture and assembly process of 2-conduit, 1-matrix biochip with three parallel channels according to the example of the present disclosure.Upper base and lower base comprise three parallel channels, and these three parallel channels are maintained in position by two cylindrical conduit supports and a matrix inlet, thereby provide the way of the inner compartment and the outer compartment entering each conduit support.In an embodiment, conduit is formed by ultra-thin porous membrane, and this ultra-thin porous membrane is bent in cylindrical mode around rod, and glue, heating or chemical method are used to combine this ultra-thin porous membrane to base at its end, and pin is assembled in the outlet matrix hole of lower base.Then, everything is sandwiched between two bases, and then chemically assisted hot pressing is used to combine them.Finally, the method can relate to rod and pin removal process, block the end of two conduit channels beyond inlet hole and outlet hole, and assemble cover glass glass on two surfaces of biochip.
[0244] Fig. 5A shows a perspective view of a 2-duct 1-matrix chip with different matrix inlets according to an example of the present disclosure. In an embodiment, a biochip can include two porous cylindrical duct channels surrounded by the same matrix chamber with different matrix inlets to allow different types of cell organs to be cultured in the same duct on a 2-duct 1-matrix biochip.
[0245] Fig. 5B shows a top view of a 2-conduit 1-substrate chip with different substrate inlets according to an example of the present disclosure. In an embodiment, a biochip may include two porous cylindrical conduit channels surrounded by the same substrate chamber with different substrate inlets, wherein each inlet may be used to inject a gel into the substrate connected thereto.
[0246] Fig. 5C shows a perspective view of a 2-duct 1-substrate chip with different substrate inlets according to an example of the present disclosure. In an embodiment, a biochip may include two porous cylindrical duct channels with different substrate inlets surrounded by the same substrate chamber, wherein the substrate chamber has a perforated barrier that is divided into two separate substrates.
[0247] Fig. 5 D shows the flow chart of the manufacture and assembly process of 2-conduit 1-matrix chip with different matrix entrances according to the example of the present disclosure.Upper base and lower base include three parallel channels, and these three parallel channels are kept in place by two cylindrical conduit supports and two different matrix entrances for each matrix chamber, thereby providing the way of the internal compartment and the external compartment entering each conduit support.In an embodiment, the matrix chamber is divided into two separate matrices by a perforated barrier, and the perforated barrier is glued at the end of the perforated barrier in the middle channel.Conduit is formed by ultra-thin porous membrane, and ultra-thin porous membrane is bent in a cylindrical manner around rod, and ultra-thin porous membrane is bonded to base at its end using glue, heating or chemical method, and pin is assembled in the outlet matrix hole of lower base.Then, everything is sandwiched between two bases, and then chemically assisted hot pressing is used to combine them.Finally, the method can relate to rod and pin removal process, block the end of two conduit channels beyond inlet hole and outlet hole, and assemble cover glass glass on two surfaces of biochip.
[0248] 6A shows a perspective view of a multiple matrix per conduit biochip with three matrices and two conduits according to an example of the present disclosure. In embodiments, the biochip may include several chambers to allow culturing of multiple types of organoids in the same conduit on a single multiple matrix per conduit biochip.
[0249] 6B shows a perspective view of a multiple matrix per conduit biochip with three matrices and two conduits according to an example of the present disclosure. In an embodiment, the biochip may include several chambers to allow culturing of the same type of organoids in the same conduit on a single multiple matrix per conduit biochip.
[0250] Fig. 6 C shows the manufacturing and the flow chart of the assembly process of multiple matrix biochips of every conduit with three matrices and two conduits according to the example of the present disclosure.Upper base and lower base comprise three parallel passages, and passage is held in place by two cylindrical conduit supports and a matrix inlet for each matrix chamber, thereby providing the way of the internal compartment and the external compartment entering each conduit support.In an embodiment, conduit is formed by ultra-thin porous membrane, and ultra-thin porous membrane is bent in a cylindrical manner around rod, and ultra-thin porous membrane is bonded to base at its end using glue, heating or chemical method, and pin is assembled in the outlet matrix hole of lower base.Then, everything is sandwiched between two bases, and then chemically assisted hot pressing is used to combine them.Finally, the method can relate to rod and pin removal process, block the end of two conduit channels beyond inlet hole and outlet hole, and assemble cover glass glass on two surfaces of biochip.
[0251] Human chip board
[0252] In an embodiment, the human body chip-board comprises cylindrical cross-section conduits surrounded by a matrix such that vascular conduits can pass through the matrix of different tissues, which also include epithelial conduits passing through their separate matrix.
[0253] In other embodiments, the biochip board uses valves between individual biochips and components so that the valves can be opened or closed manually or automatically by an operating system. In an embodiment, the present disclosure is a hybrid controlled organ chip.
[0254] A human chip board can be created by combining different individual chips together by interconnecting the different chips through their conduits to the inlet / outlet valves on the biochip and valve holding plate. A human chip board can also combine different chips in the same base, instead of having a separate component with a valve, the valve can be assembled in the biochip while assembling other components. The valves connecting the different biochip tissue growth channels can be hydraulic piston mechanisms, valves, hydraulic rolling, or pneumatically actuated membrane piston valves, or simple membrane deformation valves. Any type of valve can be incorporated into the system.
[0255] The human chip board may also include normally closed on-off valves and waste removal channels incorporated into the biochip, which is used for its potential use when assembled within the operating system. The cover glass covering the individual chip units can be made of one or more glasses that cover the surface channels of each entity, or alternatively, only one glass can be used to cover the entire surface of the biochip. The interconnections between different biochip entities can be directly through the conduit openings along their axes, or can simply reach the surrounding biochips through inlet / outlet holes. The docking of the biochip with the operating system can be achieved through the same inlet / outlet holes used in manual use, or through different holes separated from the system by normally closed valves actuated by the operating system.
[0256] In an embodiment, the system disclosed in the present invention includes a device for rotating the human chip plate about a vertical axis and / or a horizontal axis to ensure uniform distribution of reagents in the solution and uniform distribution and attachment of cells after seeding in the channels.
[0257] In an embodiment, the human body chip board allows individual biochips to be connected to each other to form a series of interconnected biochips. Additionally, in an embodiment, a specific biochip can be selectively disconnected from the remaining interconnected biochips to create multiple biochip circuits. As discussed later in this disclosure, adjustment of the fluid control mechanism allows specific valves to be opened or closed to facilitate many combinations of interconnected biochip circuits. The present disclosure allows multiple protocols to be executed in parallel within a single human body chip board because the modular nature of the human body chip board allows solutions to be dynamically laid out to specific biochips. The dynamic layout of solutions in the system of the present disclosure allows specific biochips to be isolated from the remaining biochips to allow for the execution of precision medical protocols.
[0258] In an embodiment, the human body plate fluidically connects multiple chips to each other and to other components of the operating system. These components can be, but are not limited to, any other chip, a waste chamber, or a sampling chamber. In an embodiment, the connection can be changed at any time.
[0259] 7A shows a perspective view of a human chip plate and individual chips, respectively, according to an example of the present disclosure. In an embodiment, individually removable biochips are combined together by interconnecting different chips through their conduits to inlet / outlet valves on the biochip and valve holding plate.
[0260] 7B shows a perspective view of the individual chips found in the human chip board according to an example of the present disclosure. In an embodiment, the individually removable biochips are grouped together by interconnecting the different chips through their conduits to the inlet / outlet valves on the biochip and valve holding plate, and the fluid is pumped from the top of the human chip board through the conduits and from one conduit to another conduit by a cylindrical rotary valve mechanism.
[0261] 7C shows an exploded view of a human chip board according to an example of the present disclosure. In an embodiment, the individually removable biochips are combined together by interconnecting the different chips through their conduits to the inlet / outlet valves on the biochip and valve holding plate, and the fluid is pumped from the top of the human chip board through the conduits and from one conduit to another conduit by a cylindrical rotary valve mechanism.
[0262] Figures 8A and 9A show perspective views of a human chip board according to an example of the present disclosure. In an embodiment, separate biochip entities are combined into one human chip board, where a cylindrical rotating mechanism connects the base and a valve mechanism to connect the separate chip components.
[0263] Fig. 8B and Fig. 9B show the detailed view of the valve mechanism of the individual biochip components of the connection human chip board according to the example of the present disclosure. In an embodiment, the individual biochip entities are combined into an integrated human chip. Specifically, the cylindrical rotating mechanism connects the base and the valve mechanism connecting the individual biochip components.
[0264] Figures 8C and 9C show exploded views of a human chip board according to an example of the present disclosure. In an embodiment, the individual biochip entities are combined as one component within the base and valve mechanism and connected via a cylindrical rotating mechanism.
[0265] FIG. 10A shows a detailed view of a human chip plate according to an example of the present disclosure. In an embodiment, a biochip that can be removed separately is combined by interconnecting different chips to the inlet / outlet valves on the biochip and valve holding plate through their conduits. The biochip is composed of a plurality of plate layers stacked on each other, which include a heating plate, a chip holding plate, a chip adhesion plate, a conduit 1 fluid channel plate, a matrix fluid channel tube, a conduit 2 fluid channel plate, a row actuation plane, a column 1 actuation plate, a column 2 actuation plate, and two chip actuation plates.
[0266] Figure 10B shows a schematic diagram of a human chip board according to an example of the present disclosure. In an embodiment, the heating plate includes fluid channels passing through the inlet and outlet on the top of the chip, and the heating plate is fitted into an operating system, where we can pump any liquid at any temperature to the heating plate to control, increase, decrease or maintain the temperature of the cell culture.
[0267] Figure 10C shows an exploded view of the human chip board according to an example of the present disclosure. In an embodiment, the row actuation plate is a valve actuation channel plate (3 rows, 3 signals) connected to the first bistable beam of each valve on the same row. The column 1 actuation plate is a valve actuation channel plate (2 columns, 2 signals) connected to the second bistable beam of each valve on the first two columns. The column 2 actuation plate is a valve actuation channel plate (2 columns, 2 signals) connected to the second bistable beam of each valve on the second two columns. The two chip actuation plates are valve actuation channel plates (2 conduits and 1 matrix, 3 signals) connected to the third bistable beam of each valve in each chip. In some cases, the bistable valve can open two bistable beams to each other. For example, in the case of opening the valve of the conduit 1 in the chip 1 located in row 1 and column 1 connected to the conduit 1 in the chip 2 located in row 1 and column 2, the signal will be (1, 1, 1), wherein the signal will open the first pneumatic tube in the first layer, the second layer and the fourth layer.
[0268] 11A shows a perspective view of a human chip board according to an example of the present disclosure. In an embodiment, individually removable biochips are combined together by interconnecting different chips through their conduits to inlet / outlet valves on the biochip and valve holding plate, and fluids are sampled from specific sampling points inside each biochip in the human chip board, where a pipette-like mechanism can be used or implemented in the system to obtain samples.
[0269] 12A shows a perspective view of a human chip board according to an example of the present disclosure. In an embodiment, by interconnecting different chips through their conduits to the inlet / outlet valves on the biochip and valve holding plate, individually removable biochips are combined together, and samples are collected in situ through channels, chambers and valves, wherein cell samples can be sampled in situ using a pipette-like mechanism and pumped to a sampling chamber or a culture medium chamber through a valve mechanism.
[0270] In an embodiment, separate biochip entities are combined into a human chip plate, wherein a cylindrical rotating mechanism connects a base and a valve mechanism to connect separate chip components, and fluid is pumped from the top of the human chip plate through the conduits and from one conduit to another through a valve system.
[0271] 13A shows a perspective view of a human chip board according to an example of the present disclosure. In an embodiment, separate biochip entities are combined into a human chip board, wherein a cylindrical rotating mechanism connects a base and a valve mechanism to connect separate chip components, and fluid is pumped through the side conduits of the human chip board and from one conduit to another conduit through a valve system.
[0272] In an embodiment, the individual biochip entities are combined into an integrated human chip. Specifically, a cylindrical rotating mechanism connects the base and the valve mechanism connecting the individual biochip components, and the fluid is pumped through the side conduits of the human chip plate and pumped from one conduit to another conduit through the valve system.
[0273] In an embodiment, the individual biochip entities are combined as one component within the base and valve mechanism and connected by a cylindrical rotating mechanism, and the fluid is pumped through the side ducts of the human chip board and from one duct to another through the valve system.
[0274] In an embodiment, separate biochip entities are combined into a human chip plate, wherein a cylindrical rotating mechanism connects a base and a valve mechanism to connect separate chip components, and fluid is sampled from specific areas inside each biochip in the human chip plate.
[0275] In other embodiments, the human chip plate can have biochips that can be individually removed and combined by interconnecting different chips through their conduits to inlet / outlet valves on the biochip and valve holding plate, or separate biochip entities are combined into one human chip plate, where a cylindrical rotating mechanism connects the base and valve mechanism to connect the separate chip components. In embodiments, a dual conduit chip can be connected to a single conduit chip.
[0276] Fig. 14A shows a schematic diagram of including pressure sensors at each chip inlet and outlet fluid ports to manipulate the pressure inside the chip channels. In other embodiments, due to the pressure sensors at each chip, fluid can be controllably perfused from the conduit channel to the matrix channel or from the matrix channel to the conduit channel.
[0277] In other embodiments, the on-chip biosystem board includes a plurality of conduit biochips, a fluid channel device in fluid communication with at least one biochip. The fluid channel device includes a plurality of fluid paths and an optional connection device, and the optional connection device provides the ability to connect or disconnect fluid communication with it. In other embodiments, the conduit biochip has an inlet port and an outlet port. In an embodiment, the port fluids of at least two biochips are connected to at least one fluid path. In an embodiment, the fluid channel device can transfer or circulate culture medium through the conduit or matrix area of a plurality of biochips. The optional connection device can arrange the biochip in series or in parallel according to the needs of a specific experiment or application. In other embodiments, at least one optional connection device is configured to enable a permanent selection process to be connected to it for fluid communication (e.g., a breakable fragile seal) or disconnected from it (e.g., a heat-sealable heat-bondable material) for fluid communication. In an embodiment, at least one optional connection device includes a valve device providing reversible connection and disconnection. The valve device enables isolation of the biochip during the experiment.
[0278] In an embodiment, the valve device enables access during or after an experiment to remove a sample of culture medium. The valve device enables the introduction of culture medium before or during an experiment. In addition, the valve device enables the control of the deposition position of different culture media, especially cell types, during the experimental setup, and the introduction of culture medium before or during an experiment. In an embodiment, the valve device is stable in both connected and disconnected states. In addition, several other components can be used, such as a pinch valve with a cam (friction retention or eccentric profile), a rotary valve (cylinder or ball valve with friction), a snap-on bistable lever on a pinch valve, a self-stabilizing pilot pneumatic valve.
[0279] In another embodiment, the biological system on chip plate includes a plurality of valve devices actuated by a plurality of actuators, wherein the number of actuators required for actuating the valve devices is less than the number of valve devices. In an embodiment, the biochip is a multi-catheter chip. In an embodiment, the biochip is an organ chip biosimulation. In another embodiment, a first biochip simulating a first organ type is connected to a second biochip simulating a second organ type. In an embodiment, the biological system on chip plate simulates multiple organs of an organism. The biological system on chip plate simulates enough organs to gain a deeper understanding of the effects of experimental compounds on multiple organs in an organism. In an embodiment, the organism is a human being. In another embodiment, the biological system on chip plate is configured to engage with an external actuation and pumping device to achieve a lower cost or even disposable interchangeable biological system on chip plate.
[0280] Micro valve mechanism
[0281] Figures 15A-15C show perspective views of different types of mechanical microvalves. In one embodiment of the mechanical microvalve in Figure 15A, two pistons move in opposite directions to open and close two ports, which are located in very close proximity and need to always have opposite (open-closed) forms. The hydraulic piston is connected to a constant volume of incompressible fluid, where one piston moves in one direction, and the fluid acts as a push or pull on the other piston, causing the other piston to move in the opposite direction.
[0282] Figure 15B shows a perspective view of a rolling cylinder mechanical microvalve, in which a drilled cylinder including inlet and outlet ports is rotated about its axis to align the holes toward their intended positions and connect the fluid to a microfluidic channel outside the system to connect to the fluid entering the chip.
[0283] 15C shows a perspective view of a pneumatically actuated drilled piston microvalve, where a drilled piston connected to the end of a microfluidic channel is pneumatically actuated to move the piston and block the channel.
[0284] Figures 16A-16F show multiple embodiments of an electrically actuated solenoid bistable microvalve. The microvalve includes a beam having a metal end located between two magnets, wherein an electrical signal triggers the force direction of the magnets to move the beam between two positions. The other side of the beam includes a hole, and when the hole is aligned with the microfluidic port opening of the microchannel to which it is connected, the channel will be open, and if the hole is not aligned, the channel will be closed.
[0285] 16A-16C illustrate two embodiments of electrically actuated solenoid bistable microvalves, wherein the microvalves are in an open position as the drilled beams are in their extended positions.
[0286] Figures 16B-16D show two embodiments of an electrically actuated solenoid bistable microvalve, in which the internal components of the microvalve are shown and one of the beams is in its minimum extended position, blocking the microfluidic channel, while the other beam is in its maximum position and the holes drilled in the beam are aligned with the microfluidic channel holes on which it acts, thereby opening the flow in the microfluidic channel.
[0287] Figure 16E-Figure 16F shows the assembly of the electrically actuated solenoid bistable microvalve on the human chip plate. Wherein, the plate in Figure 16E shows the microfluidic channel that the microvalve intends to block or open. In addition, Figure F shows the top view of the human chip plate with microvalve and its circuit.
[0288] Figures 17A-17D illustrate different embodiments of pneumatically actuated drilled piston microvalves. Figure 17A illustrates a perspective view of a normally closed microvalve where the drilled piston hole is not aligned with the hole connected to the microfluidic channel.
[0289] 17B shows an exploded view of a normally closed microvalve where the drilled piston hole is not aligned with the hole connected to the microfluidic channel.
[0290] FIG. 17C shows a perspective view of a normally open microvalve with the drilled piston hole aligned with the hole connected to the microfluidic channel.
[0291] FIG. 17D shows an exploded view of a normally open microvalve with the drilled piston hole aligned with the hole connected to the microfluidic channel.
[0292] FIG. 18A shows a perspective view of a bistable beam on a flexible tube microvalve of a separate biochip component of a human chip board according to an example of the present disclosure. In an embodiment, the valve mechanism connecting the separate biochip components is bistable, wherein the microvalve has two stable positions. The bottom balloon channel is pneumatically actuated, wherein when air flows in the channel, it opens all channels in the microvalve, and the upper group of balloons is pneumatically actuated individually, each balloon closing the channel below it.
[0293] Figure 18B shows an exploded view of a bistable beam on a flexible tube microvalve of a separate biochip component of a human chip board connected according to an example of the present disclosure. In an embodiment, the valve mechanism connecting the separate biochip components is bistable, wherein the microvalve has two stable positions. The microvalve requires power only when switching between the two states, and once actuated, the bistable beam will stay in one of the two bistable positions. The bottom balloon channel is pneumatically actuated, wherein when air flows in the channel, it opens all channels in the microvalve, and the upper group of balloons is pneumatically actuated individually, and each balloon closes the channel below the balloon by squeezing the tube to block the flow.
[0294] FIG. 19A shows a perspective view of a bistable magnetic drilled piston microvalve of a separate biochip component connected to a human chip board according to an example of the present disclosure. In an embodiment, the valve mechanism connecting the separate biochip components is bistable, wherein the microvalve has two stable positions. The bottom channel and the upper channel are magnetic, which makes the microvalve bistable, and the drilled piston is pneumatically actuated, which controls the state of the microvalve.
[0295] Figure 19B shows an exploded view of a bistable magnetic drilled piston microvalve of a separate biochip component of a human chip board connected according to an example of the present disclosure. In an embodiment, the valve mechanism connecting the separate biochip components is bistable, wherein the microvalve has two stable positions. The bottom channel and the upper channel are magnetic, which makes the microvalve bistable by attaching a drilled piston to the surface of the channel, wherein the drilled piston can be replaced by a spherical microvalve. The drilled piston is pneumatically actuated, which controls the state of the microvalve to be opened or closed, wherein the drilled piston is any piston with a hole, and the hole can be concentric with the conduit in the open position to allow fluid to pass.
[0296] Figure 20A, Figure 20B, Figure 20C and Figure 20D show different perspective views of the bistable mechanically actuated flexible tube microvalve of the individual biochip components of the connection human chip board according to the example of the present disclosure. In an embodiment, the valve mechanism connecting the individual biochip components is bistable, wherein the microvalve has two stable positions. The bistable beam is mechanically actuated, wherein when closed, the bistable beam squeezes the flexible tube to prevent any fluid from passing. The design can be solenoid or pneumatically actuated to move the main beam, which actuates the bistable beam, and the bistable beam can be replaced by a bistable magnetic piston.
[0297] Figures 21A, 21B, 21C, and 21D show different perspective views of mechanically actuated squeeze ball open and close microvalve of a separate biochip component connected to a human chip board according to an example of the present disclosure. In an embodiment, the valve mechanism connecting the separate biochip component is open or closed, wherein the microvalve with a ball with a slotted hole can be rotated to allow fluid to pass or block the fluid. The spherical microvalve is mechanically actuated by a motor controlled by a system that can be actuated by a robot that moves in a 2D or 3D plane that opens and closes the microvalve, or in an independent system that can preset the microvalve configuration to simulate an organ in the human body.
[0298] Figures 22A, 22B, 22C and 22D show different perspective views of a permanent sealed open and close microvalve of a separate biochip component connected to a human chip board according to an example of the present disclosure. In an embodiment, the valve mechanism connecting the separate biochip components is open or closed, wherein the permanent seal is preset once to have an open or closed microvalve, wherein a pin is permanently inserted into a channel and blocks or opens the channel depending on the shape of the pin.
[0299] Operating system components
[0300] Figures 23A-23K show perspective views of an embodiment of an assembled operating system. In an embodiment, the operating system is composed of multiple interconnected subsystems. The subsystems are a mixing chamber, a fluid control operating system, a human chip board, individual biochip components, a machine control system, and an analytical equipment system.
[0301] FIG23G shows a port on one side of the device that connects the operating system to the tube that comes out of the chip and goes into the waste chamber. FIG23G also shows a port that connects the operating system to a pneumatic air signal inlet that will actuate a valve that controls flow to the waste chamber. In addition to the fluid tube that allows temperature control fluid to enter the system to heat the system, there is also a pneumatic port for actuating a valve that controls the flow of thermal control fluid to evenly distribute heat throughout the system.
[0302] Figure 23F also shows two ports connected to the pneumatic control device on the back side of the device. One port includes 11 pipe fittings, which are intended to pneumatically control 33 valves in the chip, and the other port includes 16 pneumatic pipe fittings, which are intended to control 72 valves of 72 culture medium microchambers, which will be pumped into 72 different channels in the human chip board. On the same side, the device has 72 fluid ports, which connect fluids from outside the system to the culture medium microchambers. These fluids enter the valve distributor from the mixing chamber and then enter these ports.
[0303] Figure 23G shows the side of four electrical plugs including sensors for controlling temperature, pressure / flow, O2 and CO2 respectively.
[0304] Figure 23H shows a human chip board connected to a fluid manipulation system, wherein Figure 23I shows a port in the fluid manipulation system device that connects a biological fluid port to each channel of the human chip board, and also shows a pneumatic air control port connected to a valve inside the human chip board and a heating fluid port connected to a heating human chip. Figure 23J shows three main components in the system, which are a fluid manipulation system device, a culture medium chamber connected to the fluid manipulation system device, and a human chip board.
[0305] In an embodiment, a fluid composed of cells or biological or chemical components (which we call culture medium) is first manually injected into a mixing chamber by a user. After entering the mixing chamber, the culture medium is pumped into the tube of the fluid operating system through a pressure sensor and a bubble filter and a 1-to-12way valve.
[0306] The 1 to 12-way valve allows the culture medium to be transferred from a predetermined mixing chamber to the operating system before being distributed by the valve system, which is the first subsystem in the fluid operating system. The distribution valve consists of a combination of valves: a 1-12-way valve, which is connected to 12 other 1-6-way valves to form a 1-72 layout path. The culture medium then arrives at a microchamber positioned very close to the human chip. The microchamber is docked with a pumping mechanism, where the fluid inside the microchamber is accurately pumped to a channel in the chip entity of the human chip or pumped to a waste chamber.
[0307] In an embodiment, a microfluidic pumping mechanism controls the precise amount of fluid, which may be as low as 0.1 μl, that is pumped to and from the microchamber to the chip.
[0308] In an embodiment, each channel of the chip has an inlet port and an outlet port, and a pumping control mechanism can control the pressure, flow rate, and flow direction.
[0309] In an embodiment, at least one analytical device may be used for real-time measurement of a chemical, biological or physical parameter.
[0310] In an embodiment, the operating system includes pressure sensors at each chip inlet and outlet fluid ports to manipulate the pressure within the chip channels. This allows fluid to be controllably perfused from the conduit channels to the matrix channels, or vice versa.
[0311] In an embodiment of the operating system, at least one valve system can open or close the flow path to each compartment and can switch the flow path to each compartment when an experiment is running.
[0312] In an embodiment of the operating system, conduit holders of multiple organ chips on a human chip board are connected together to allow continuous flow.
[0313] In an embodiment of the operating system, the conduit supports of multiple organ chips on a human chip board are connected together only for a controllable amount of time.
[0314] In an embodiment of the operating system, multiple organ chips on a human chip board are isolated from each other.
[0315] In an embodiment of the operating system, a microfluidic automated flow control mechanism allows for the addition and removal of fluids in the conduit scaffolds of the Organ Chip.
[0316] In an embodiment of the operating system, a microfluidic automated flow control mechanism allows for the addition and removal of fluids in the conduit holders of multiple organ chips on a human chip board.
[0317] In an embodiment of the operating system, a microfluidic automated flow control mechanism allows fluid to be added to and removed from an external compartment surrounding the conduit support of the Organ Chip.
[0318] In embodiments of the operating system, a pumping control mechanism may deliver the pumped fluid to a waste chamber.
[0319] In embodiments of the operating system, a pumping control mechanism may deliver the pumped fluid to the sample chamber.
[0320] In an embodiment of the operating system, the pumping control mechanism can deliver the pumped fluid to different biochips.
[0321] In an embodiment of the system, a pumping control mechanism may deliver the pumped fluid for sampling.
[0322] In an embodiment of the operating system, an electromechanically controlled robotic arm embedded in and interconnected to the operating system can be operated in at least one dimension to perform different operations.
[0323] In an embodiment of the operating system, an electromechanically controlled robotic arm embedded in and interconnected to the operating system can position at least a built-in microscope, a spectroscope or a monitoring sensor above the human chip.
[0324] In an embodiment of the operating system, an electromechanically controlled robotic arm embedded in and interconnected to the operating system may have at least one built-in pipette that can retrieve a sample from at least one compartment of a sample source chamber.
[0325] In an embodiment of the operating system, an electromechanically controlled robotic arm embedded in and interconnected to the operating system may have at least one socket head that can engage and actuate at least one type of mechanically actuated valve.
[0326] Operating system fluid control mechanism
[0327] In an embodiment, the fluid control mechanism allows the use and manipulation of microliters of fluid used in biochip cell culture without losing milliliters of fluid as lost volume in the tube on the way to the biochip channel, as shown in Figures 23F, 23G and 23H. The proximity of the biochip channels, the valve mechanism and the small separate culture medium chambers for each inlet hole and outlet hole in the system play an important role in this system. In an embodiment, a piston pumping mechanism is used to inject fluid into the separate culture medium chambers and pump it to the biochip.
[0328] Figure 25, Figure 26, Figure 27 and Figure 28 show several designs of fluid control mechanisms of operating systems based on the channel of biochip and the channel docking of machine. The machine will control the movement of the valve incorporated in the biochip in the mechanism depending on the valve type, mainly the inlet / outlet hole valve. In an embodiment, if the valve is mechanical, the valve can be actuated by a micro linear actuator in the system. In addition, if the valve is a normally open on-off valve, these valves can be mechanically or pneumatically actuated by an actuator incorporated in the system or by an actuator docking portion in a system actuated from outside the system.
[0329] Figure 28 shows the docking part of the operating system and the biochip, and the first level of fluid control beyond the inlet hole / exit hole and the separate compartment docking part open / close are three valves in series. The first valve is an on-off valve, which opens / closes the channel from the biochip to the operating system. The second valve is a waste channel direction conversion valve, which flips the direction of the flow to the second on-off valve or the waste microchannel. If the valve is on the biochip, the second on-off valve or the waste microchannel is combined inside the human chip, or if the valve is in the layered plate docked with the biochip, the second on-off valve or the waste microchannel is combined on the layered plate. The third valve is the second on-off valve, which uses the operating system to separate the waste valve and the first on-off valve connected to the biochip channel from the culture medium chamber plate. In the case of cheap valves used, for example, in the case of a membrane deformation valve pneumatically actuated from the outside of the system, three valves in series and waste microchannels can be combined into the biochip itself. Alternatively the operating system valves can be incorporated on a separate plate assembled on top of the biochip, mainly in cases where the valves are expensive or actuated from the same location of the valves, such as solenoid magnet actuators or bending motor actuators.
[0330] At the interface with the chip holes, we can add plates that can create different layouts for different conduits and microfluidic channels. This chip plate can be basic in cases where valves are not included in the design of the human chip, or in cases where this layout plate is used to connect different individual chips to create a new human chip assembly.
[0331] At the docking portion, the three valves in series are docked to individual holes of the culture medium chamber plate. In the case where the three valves in series are also incorporated in the biochip, the operating system chamber can also be incorporated in the biochip above the biochip surface, or can be incorporated in a separate plate, which is the preferred case, i.e., docked to the biochip surface or to the surface of the series valve plate. Each individual culture medium chamber in the plate is preferably fed into a single inlet / outlet hole, can accommodate several hundred microliters of fluid, and is actuated from above by a piston incorporated in the plate.
[0332] At the docking portion with the culture medium chamber plate is a piston plate, which includes a piston for each culture medium chamber to be actuated separately. Each piston in the piston plate consists of two sub-components. The lower part of the piston has a bottom surface cross-section of the same size and shape as the culture medium chamber it operates. In addition, the piston includes a channel passing through its length, which leads to the upper part of the piston. The upper part of the piston includes a docking portion with the lower piston part on its lower surface. The docking portion leads to a channel, which connects the channel of the lower piston part open at the culture medium chamber to the side of the upper part of the piston, and the pipe docking portion for obtaining the culture medium from the culture medium chamber through the piston toward the top valve plate is located on the side of the upper part. The complete piston plate is assembled by inserting the lower piston part from below into the plate including the hole for the piston, and inserting the upper piston part into their respective pistons from the other side. The top surface of the upper piston part includes a pressure blocking docking feature, which docks with the corresponding piston actuator included in the piston actuator plate.
[0333] At the docking part with the piston plate is the piston actuator plate, which includes an actuator for each piston. The actuator can be directly connected to the piston, or connected by reaching the connector of the actuator outside the system. As shown in Figure 27I and Figure 27J, the actuator included in the operating system docked with the piston plate is preferably small-sized, dissipates the minimum heat, and moves a small and controllable step length, and the perfect example of this aspect is a waveform motor (squiggle motor). Other motors can be used in the system, such as solenoid magnetic actuators or small stepping motors. For the actuator outside the operating system, any actuator type can be used, as long as the docking part is easy to produce minimum error. Therefore, pneumatic or hydraulic actuators can be used for actuating pistons from outside the system, as long as the pipe that the operating system external actuator is connected to the system is thermally sealed and takes into account the compressibility of gas.
[0334] The tube connected to the piston supplied to the small culture medium chamber extends to the top opening and closing valve plate, which is located above or beside the piston plate at the minimum distance from the piston plate. The opening and closing valve plate includes a valve, which connects and separates each tube that reaches the culture medium source plate from the small culture medium chamber through the piston. Each individual opening and closing valve can be any small volume or small size valve, it can be a solenoid magnetic actuated valve actuated in situ, or any other valve type electronically actuated from its position. Each individual opening and closing valve can also be a membrane or piston-based valve, which is pneumatically or hydraulically actuated by a tube that reaches an actuator outside the system.
[0335] The pipe that leaves the top valve plate leads to the fluid source plate, and the fluid source plate is the plate that is connected with the mechanism for fluid injection. Independent syringe can be matched in the inlet of fluid injection plate, and fluid injection plate can be used for certain types of experiments. In addition, the culture medium source chamber plate mechanism also can be connected to the culture medium source plate. This culture medium source chamber plate has its own valve and pumping system, which is outside the operating system, but can be controlled by identical software. The main external chamber is connected to the valve plate with microvalve grid, and the microvalve grid can open, mixed culture medium and make culture medium flow to any inlet of the source plate in the operating system from any culture medium chamber on the external plate. From the other side of the fluid source plate inside the operating system, the three-way valve can be incorporated into the system to serve as a pressure release outlet, and any bubble that may be produced due to the docking when pipe or syringe is connected to the operating system can also be removed from the system.
[0336] Fluids, cells and other biological components exiting the system can be sampled and aliquoted at any designed time interval by pumping and opening and closing their respective valves. In addition, the tubes exiting the system are interfaced with various measurement technologies, such as Fourier Transform Infrared (FTIR) spectroscopy equipment, O2 and CO2 sensing equipment, and pH sensing equipment placed along the tubes exiting the system.
[0337] In an embodiment, the human chip board includes a manifold that ensures that the internal space of the system is maintained at specific environmental conditions that can be adjusted for specific testing protocols. In addition, a heat sink or heat generator can be used to mitigate undesirable temperature conditions.
[0338] In an embodiment, the human chip plate includes a fluid control system capable of delivering and / or collecting the necessary reagents at the channels of one or more biochips within the system at precise times and in an operating system, which is required to perform analytical assays as shown in Figures 29A and 29B. These assays can be measured with a built-in microscope, spectrometer and / or FTIR, or any other suitable analytical equipment with or without built-in measurement.
[0339] In an embodiment, the human chip board includes a fluid control system that can deliver and / or collect liquid samples from any channel in any biochip within the operating system. The collected or delivered liquid samples may include any desired chemical or biological materials, including but not limited to cells, enzymes, drugs, growth factors, nutrients, etc. The volume of the sample delivered to each channel can be between 0.5 μl and 25 μl.
[0340] In an embodiment, the human chip plate includes a fluid control system that can pump liquid samples from any channel in any biochip in the operating system. These liquid samples can be pumped from the top inlet hole or from the side. The fluids delivered to multiple channels in each biochip and / or across different biochips in the operating system can be the same or different. Gases can also be pumped in one or more channels instead of fluids. Liquids or gases can also be pumped at different flow rates. The delivered liquid can contain chemicals, drugs, polymers, biomaterials, cells, growth factors, nutrients or any other substances.
[0341] In an embodiment, the human chip board includes a fluid control system that can deliver a polymeric substance, which may include cells or other biological or chemical substances, to any or multiple channels (matrix and / or conduits) of one or more biochips within the operating system. The control system will be connected to a temperature controller to ensure that the temperature is maintained so that the polymeric substance is in its liquid state until the polymeric substance is delivered to the desired conduit. Once the polymeric substance is delivered, the temperature will be increased to ensure gelation.
[0342] 30A and 30B show flow charts for pumping samples from a culture chamber to a biochip and from the biochip to a measurement device such as an ATR FTIR, respectively.
[0343] Mixing chamber
[0344] Figure 32A, Figure 32B, Figure 32C and Figure 32D show some schematic diagrams of the mixing chamber and part thereof according to the example of the present disclosure.In an embodiment, the fluid (we call it culture medium) composed of cells or biological or chemical components is first manually injected into the mixing chamber by the user, and gas bubbling and heating element heating fluid are heated in the mixing chamber.Then, the system automatically distributes culture medium to any other parts of one or more biochips, waste chambers or operating systems.O2, CO2 and temperature sensors are used to keep physical parameters at the level set by the user.
[0345] In an embodiment, the pumping mechanism is pressure driven and pneumatically actuated through an air tube reused from a pressure control system.
[0346] In another embodiment, the pumping system mechanism is driven by a syringe pump, where the fluid is pushed through the system via a syringe.
[0347] In another embodiment, the pumping mechanism is peristaltic pump driven, wherein the fluid in the container is drawn in and pumped into the system.
[0348] Figure 33 shows several flow chart scenarios of an embodiment of a mixing chamber in an example of the present disclosure. In an embodiment, after being in the mixing chamber, the culture medium is pumped into a fluid control operating system, where the fluid passes through a pressure sensor and bubble filter while still in the mixing chamber and a 1 to 12 way valve that draws fluid from one of the containers of the mixing chamber into a tube of the fluid operating system.
[0349] Sensors and controllers for CO2, O2 and temperature
[0350] FIG34A shows a flow chart of an embodiment of a mixing chamber in an example of the present disclosure, wherein all containers have access to O2, CO2, and N2 bottles and O2 and CO2 sensors. When the culture medium is in the container of the mixing chamber, the gas is bubbled and the heating element heats the fluid. The O2, CO2, and temperature sensors are used to maintain the physical parameters at the levels set by the user.
[0351] In an embodiment, O2, CO2 and temperature control systems are also applied and measured at the level of cells and media physically in the chip, not just in the mixing chamber, as shown in Figure 34B. This provides insight into the metabolic activity of the cells and more precise control over those physical parameters.
[0352] In an embodiment, O2 and CO2 are pumped directly into a container of a mixing chamber in a closed loop control system, where optical or biochemical sensors measure the ratio of diffused O2 and CO2 in the fluid.
[0353] In an embodiment, temperature is sensed by a heating element and measured using a thermal sensor, where the temperature is controlled by a feedback control system, as shown in Figures 35A and 35B.
[0354] Solution injection
[0355] In an embodiment, in order to fill the culture medium chamber, as shown in Figure 28B, the user of the system repeats two steps until the culture medium chamber is filled. In the first step, the valve below the culture medium chamber is closed to prevent the flow to the biochip or waste channel, and the valve above the culture medium chamber is opened before the culture medium source plate to inject the fluid from the source plate. After opening the valve, the piston is pulled upward to pump the fluid from the source plate toward the culture medium chamber. Due to the small volume of the culture medium chamber (hundreds of microliters), the volume of the tube from the source plate to the culture medium chamber is large, so the piston will reach the topmost position before the culture medium reaches the culture medium chamber in the tube. When the piston reaches its topmost position, the valve below the culture medium chamber and the waste channel valve are opened, and the valve leading to the biochip channel and the top valve before the culture medium source plate are closed. After opening and closing the corresponding valves, the piston is pushed downward to remove excess air from the culture medium chamber. When the piston reaches its bottommost position, step 1 is repeated, and then step 2 is repeated until the culture medium fills the tube and reaches and fills the culture medium chamber. In an embodiment, the solution can be a cell culture medium.
[0356] Solution replacement
[0357] In order to empty the culture medium chamber, as shown in Figure 28C, the user of the system should repeat two steps until the culture medium chamber is emptied. In the first step, the valve below the culture medium chamber is closed to prevent the flow to the biochip or waste channel, and the valve above the culture medium chamber is opened before the culture medium source plate to push the fluid into the source plate. After opening the valve, the piston is pushed downward to pump the fluid from the culture medium chamber toward the source plate. Due to the small volume of the culture medium chamber (hundreds of microliters), the volume of the tube that arrives at the culture medium chamber from the source plate is large, so the piston will reach the bottommost position before the culture medium arrives at the source plate in the tube. When the piston reaches its bottommost position, the valve below the culture medium chamber and the waste channel valve are opened, and the valve leading to the biochip channel and the top valve before the culture medium source plate are closed. After opening and closing the corresponding valve, the piston is pulled upward to fill the culture medium chamber with additional air. When the piston reaches its topmost position, step 1 is repeated, and then step 2 is repeated until the culture medium empties the tube and arrives at the source plate. In an embodiment, the solution can be a cell culture medium.
[0358] Cell injection
[0359] In order to inoculate cells into the biochip channel, as described in Figure 28D, the user should first inject the culture medium containing cells into the culture medium chamber in the same manner as described in Figure 28B and the method of filling the culture medium chamber. Then, the user should open the valve below the culture medium chamber on both sides of the waste valve to allow the flow to reach the biochip, and close the valve of the waste channel to stop the flow toward the waste channel. Then, the user should close the valve above the culture medium chamber before the culture medium source plate to stop the flow from the source plate and the flow to the source plate. After opening the valve, the user should open the outlet waste valve to push the excess air or culture medium to the outside of the system to replace them with the culture medium filled with cells, and then push the piston downward to pump the fluid from the culture medium chamber toward the biochip channel. If the same cells need to be inoculated into different biochips, the user can open the channel between different biochips from the outlet so that the opened outlet waste channel will be the last biochip that the cells need to reach. After the cells reach their expected position, close all valves and stop pumping, and wait for the cells to attach. After the cells settle on the bottom surface of the conduit and attach, flip the entire operating system, then open the same valve and perform the same steps, then pump the cells into the biochip conduit and wait for the cells to attach to the top surface of the conduit. After the cells settle on the top surface of the conduit and attach, flip the entire operating system to its initial form and continue the experiment.
[0360] In an embodiment, cells can be injected into the biochip through any available channel, including but not limited to side channels. Cells can be injected so as to be suspended in a suitable liquid or a suitable polymer that will solidify.
[0361] In an embodiment, skin tissue may be cultured into a plurality of biochips to allow a human-on-a-chip operating system to execute protocols related to, but not limited to, the assessment of skin health and physiology.
[0362] In an embodiment, cells, culture medium or any other substance can be injected into any channel of the biochip or a specific location in any biochip in the operating system. Cells can also be sampled by delivering appropriate enzymes or other reagents that will cause cells to detach at a specific location, but not exclusively. Once the cells detach, the fluid control system will collect the suspended cells.
[0363] Culture medium sampling
[0364] In an embodiment, in order to collect culture medium samples from the biochip channel described in Figure 28E, the user of the system should repeat two steps until the culture medium chamber is filled with the expected sample amount. In the first step, for both the inlet fluid channel and the outlet fluid channel, the valve below the culture medium chamber on both sides of the waste valve is opened to allow the flow from the biochip and the flow to reach the biochip, and the valve of the waste channel is closed to stop the flow towards the waste channel. Then, the valve above the culture medium chamber should be closed before the culture medium source plate to stop the flow from the source plate and the flow to the source plate. After opening and closing the expected valve, the piston of the control inlet fluid is pushed downward, and at the same rate and volume, the piston of the control outlet piston is pulled upward to collect the sample of the expected volume in the outlet culture medium chamber. After collecting the expected sample in the culture medium chamber, step 2 is started, and step 2 transmits the collected sample upward to the system by emptying the outlet culture medium chamber. The emptying process is as previously described in Figure 28C.
[0365] In an embodiment, culture medium samples are collected from any biochip channel within the operating system. In some cases, culture medium or any other liquid substance will be collected from a side channel.
[0366] Cell sampling
[0367] In one embodiment of the operating system, the same cell or tissue type can be grown on different chips with common conduits. Thus, each biochip represents a subsample of the same organ. Each individual biochip can then be independently removed from the circulation system and taken out of the system at different time points for downstream analysis. This allows sampling at different time points.
[0368] In one embodiment of the operating system, the same cell or tissue type can be grown on different biochips with common conduits. When dosing, the biochips can be separated from each other. Each individual biochip can then be sampled or removed independently for downstream analysis.
[0369] In order to collect cell samples from the biochip channel described in Figure 28F, four steps should be performed until the culture medium chamber is filled with the expected sample amount. In the first step, the biochips were previously connected along their conduits to make them a continuous tissue sample, so each biochip obtained at different time intervals is a sample of the same tissue. Therefore, in the first step, this docking is required. In the second step, the valves between different biochip entities should be closed so that each biochip conduit becomes a sample collected at a specific time point. At this stage, as previously described, the expected valve and pump are blocked to replace the culture medium with trypsin in the culture medium chamber of the entrance of the biochip intended to collect cell samples therein. In the third step, trypsin should be pumped into the expected culture medium channel as previously described, and the cell sample is collected in the outlet culture medium chamber in the same manner as the collection culture medium sample. In step 4, after collecting the expected sample in the culture medium chamber, the collected sample is transmitted upward to the system by emptying the outlet culture medium chamber. The emptying process is as previously described in Figure 28C.
[0370] In an embodiment, cells, culture medium or any other material can be sampled from a specific location in any channel of a biochip or any biochip in an operating system. Cells can also be sampled by delivering, but not exclusively, a suitable enzyme or other reagent that causes cells to break away from a specific location. Once cells are broken away from, the fluid control system will collect suspended cells. Sampling can be carried out from the inlet hole and outlet hole of a biochip. In some cases, cell sampling can be carried out from the side channel of an operating system.
[0371] Inject multiple reagents sequentially
[0372] In one embodiment of the operating system, we can add reagents sequentially. In order to fill the culture chamber with the first reagent as described above, the culture chamber is then injected into the matrix chamber of the biochip. As described above, the culture chamber is then emptied and filled with a different reagent, which can then be injected into the matrix chamber. This can be repeated as many times as needed. The time between adding different reagents to the matrix chamber is controllable and programmable. Different reagents can be added one by one immediately or after a set time interval.
[0373] In embodiments, sequential injection of reagents is necessary not only for dosing with multiple chemicals, but also when running assays, including but not limited to chip immunohistochemistry and cell health assays.
[0374] Tubular architecture and barrier function of ductal tissue
[0375] Figure 39E shows an embodiment, and this system is used as a blood-brain barrier model for drug screening and permeation studies. Here, the catheter will be filled with brain microvascular endothelial central nervous system cells docked with tissue composed of pericytes, astrocytes and neurons. It is then used to perform drug permeability testing and / or toxicity and efficacy analysis on neural tissue.
[0376] Cultivate multiple tissues in different chips connected by common conduits / vessels
[0377] Figure 39B shows a perspective view of an embodiment of multiple cultured tissues in our chip connected to a common conduit / vessel. In one embodiment of the operating system, it can be used to study the microbiota-gut-brain axis. Here, the matrix chamber of one biochip includes intestinal epithelial cells layered with intestinal mucus and patient-derived microbial components. The culture medium in the matrix chamber is anoxic. The conduits connecting the various biochips are seeded with vascular endothelial cells, and the culture medium flowing through them is fully oxygenated. Another biochip includes cultured neurons, astrocytes, and microglia embedded in a hydrogel matrix. The effects of different microbiota on the brain biochip can be evaluated by microscopic examination of neural cells or by sampling and running protein and gene expression assays outside the system.
[0378] Figure 39B is a perspective view of an embodiment of multiple cultured tissues connected to a common conduit / blood vessel in our chip. In one embodiment of the system, it can be configured so that each biochip includes different tissues and organ systems, but these are connected in parallel and / or in series through a common conduit or a conduit simulating a blood vessel and / or lymphatic system. Some biochips may have multiple conduits that can be interconnected with one or more other biochips. In short, this will be a human chip and is valuable for screening off-target and / or systemic effects of drugs and the permeability of drugs through different anatomical barriers. It can also more accurately indicate the in vivo half-life of a drug.
[0379] In an embodiment, the system can be configured to evaluate hepatotoxicity and nephrotoxicity simultaneously in drug screening. Since both kidney and liver are responsible for the removal and metabolism of xenobiotics, it is essential to evaluate the efficacy of drugs in the presence of these two tissues. In this embodiment, one or more biochips include renal epithelium and another (or more) biochip hepatocytes, as described elsewhere herein. The two tissues are connected by a conduit lined with endothelial cells. The drug is dissolved in the conduit, and cytotoxicity, proliferation and apoptosis determination can be obtained on two biochips using spectroscopy. The system can also be configured to include one or more tissues in a separate biochip, which is the target organ for the test drug.
[0380] Figure 39A shows a cross-sectional view of an embodiment of the tubular architecture of tissues in our 2-conduit chip. In an embodiment, the system provides for at least two different tissues to grow in direct contact (one in a conduit surrounded by a second tissue) or via one or more conduits (blood vessels or lymphatic vessels or both). This allows tissue-tissue interaction studies.
[0381] Embodiments of the system, wherein the biochip board may include different independent biochips, each biochip having a specific tissue. The board may also include another set of biochips, which form a human chip, and the human chip is interconnected with other chips through one or more conduits.
[0382] Liquid-Air Interface Lung Chip
[0383] In an embodiment, as shown in Figure 39C, the system can be used to test the gas exchange in the lung to study the model of the efficacy of lung physiology, disease and candidate drugs.Human epithelial cells and lung endothelial cells are cultured in the matrix gel in the external compartment including one or two conduits. One conduit has human small airway epithelial cells attached to the inner wall growth of the conduit support. Air is pumped through the lumen of the conduit. If there is a second conduit, it may include vascular cells, epithelial cells and pericytes to reproduce capillaries. Under a constant pressure of 30mmHg, the conduit has a constant red blood cell flow of 5-0.03cm / s. Similarly, in an embodiment, air can be pumped through the matrix channel of the chip, and cells can grow in one or more conduits present in the chip.
[0384] Immune system model
[0385] In an embodiment, as shown in Figure 39D, the system provides components of the circulating immune system, such as but not limited to T cells, natural killer cells and / or B cells, to be added to a single or multiple chips within the system. This allows tissue (or tumor)-immune system interaction studies and immunotherapy efficacy studies.
[0386] In an embodiment, the system provides components that can add engineered immune components (such as but not limited to CAR-T cells) to a single or multiple chips within the system. This allows the system to be used to evaluate the efficacy and toxicity of immunotherapy.
[0387] In one embodiment of the operating system, is the modeling of the immune system. This can include simulating one or more of the following organs on one or more chips within the system: spleen, bone marrow and / or lymph nodes. These can be used as independent organs or connected to other organs to study the interaction of the immune system with other components.
[0388] Biopsy culture for precision and personalized medicine drug prognosis
[0389] In an embodiment, the system can be used for precision medicine, where biopsies or primary cells from patients can be grown in 3D space to recreate the physiological / disease architecture. Drugs can then be administered to the system according to the processes and methods disclosed herein, and specific toxicity and efficacy tests can be performed to quantify the effectiveness of the drug or drug combination.
[0390] In an embodiment, primary cells from different patients can be grown on different biochips independent of each other.
[0391] In an embodiment, biochips comprising different cells from the same patient can be connected to each other to form a human plate.
[0392] Microscope measurement docking
[0393] In another embodiment of the operating system, the system is capable of performing real-time live cell imaging as well as endpoint imaging for, but not limited to, visualization of cells, cell components and / or tissue morphology. These can help assess cell proliferation, migration and / or death, etc. The integrated system software then analyzes the images to provide quantitative data.
[0394] In one embodiment of the operating system, it uses fluorescence and bright field microscopy for time-lapse tissue culture imaging. In another embodiment of the operating system, the system is able to repair and complete all steps for performing immunohistochemistry and / or immunofluorescence staining, followed by automated imaging using fluorescence and / or bright field microscopy, followed by high throughput image analysis.
[0395] In another embodiment of the operating system, it can be used for testing and screening of drugs and drug ingredients.
[0396] Spectral measurement docking
[0397] In one embodiment of the operating system, high throughput absorbance and colorimetric assays can be performed to assess the physiological state of tissue. Some but not all specific parameters that can be measured include cell health, vigor, enzyme function or cytochrome activity. In another embodiment of the operating system, high throughput fluorescence assays can be used to assess cell metabolism, vigor, health, cell death, ADME toxicology or other parameters. In another embodiment of the operating system, high throughput luminescence assays can be performed to assess cell health, metabolism, vigor, cell proliferation, ADME toxicology, luciferase activity, inflammation, oxidative stress or apoptosis and / or any other assay using the technology.
[0398] In another embodiment of the operating system, the combination of fluorescence, colorimetry, absorbance and luminescence spectroscopy allows for single or multiplexed assays to assess cellular functions and processes, such as, but not limited to, basic indicators of cell health (cell proliferation, cell viability and cytotoxicity, specific mechanisms of cell death, such as apoptosis or necrosis) and / or cellular processes (e.g., metabolism, inflammation, cytochrome p450 activity, oxidative stress or autophagy). Briefly, in these assays, reagents are added to the biochip, which interact with the cellular components of interest and emit luminescence, fluorescence or change the turbidity of the culture medium, which is recorded by a spectrophotometer within the system.
[0399] Fourier transform infrared spectroscopy measurement docking
[0400] In an embodiment of the operational system, ATR-FTIR will be used as a measurement technique for cellular expression and function, which is achieved by delivering micro-volume culture medium samples from the biochip through a set of valves and tubes operated in a software-controlled sequence at multiple time points.
[0401] In another embodiment of the operational system, ATR-FTIR will perform tests to study the efficacy or toxicity of the introduced drug, which include but are not limited to elemental footprint, amide I, amide II, and molecular structure.
[0402] In another embodiment of the operating system, the ATR-FTIR system can detect at least one sample having a thickness of at least 2.3 microns, and the ATR-FTIR system includes at least one ATR crystal having a certain refractive index. The ATR crystal can have a refractive index in the range of 1.38 to 4.2. In other embodiments, the system of the present disclosure can utilize the use of sample aperture signal noise reduction and / or software base signal noise reduction by implementing a mapping mode with reference to a pre-created FTIR database.
[0403] In another embodiment of the operating system, the automatic ATR is covered with sensors to detect whether the sample is correctly in its position. The ATR crystal cleaning system consists of valves, tubes and buffer solutions controlled by software. After the cleaning is completed, a test is performed by checking the refractive index and cross-referencing it with the actual index. If the refractive index is equal to the actual refractive index, it means that the ATR crystal is clean. If not, the operating system will perform another cleaning cycle.
[0404] ATR-FTIR measures cellular responses to drugs by providing quantitative data on drug uptake, metabolism and cellular expression. A selective set of data from ATR-FTIR will be stored in the operational system and then cross-referenced with other measurement techniques to further validate the results obtained.
[0405] It should be understood that various changes and modifications to the example embodiments described herein will be apparent to those skilled in the art. Such changes and modifications may be made without departing from the spirit and scope of the present subject matter and without diminishing the intended advantages of the present subject matter. Therefore, the appended claims are intended to cover such changes and modifications. In addition, it should be understood that the features of the dependent claims may be embodied in the systems, methods, and apparatus of each independent claim.
[0406] Once having benefited from the teachings in the foregoing description and the associated drawings, those skilled in the art to which the present disclosure belongs will think of many modifications and other embodiments of the present disclosure set forth herein. Therefore, it should be understood that the present disclosure is not limited to the specific embodiments disclosed, and modifications and embodiments are intended to be included within the scope of the appended claims. Although specific terms are employed herein, these terms are used in a general and descriptive sense only and are not used for the purpose of limitation.
Claims
1. A biochip operating system, comprising: at least one biological system on the chip board; at least one valve device; at least one actuating means for actuating said valve means; at least one fluid handling device; at least one analytical device; and A control system for controlling the pumping device, the actuating device and the valve device, and the analyzing device.
2. The biochip operating system according to claim 1, wherein: The analysis device is capable of inspecting the biochip using at least one of microscopic images or spectroscopic measurements.
3. The biochip operating system according to claim 1, wherein: The analysis device is capable of examining culture medium in the fluid handling apparatus or fluid path.
4. The biochip operating system according to claim 1, wherein: The operating system facilitates, semi-automates, or automates at least one aspect of an experimental setup, including at least one of: cleaning, sterilizing, or preparing the system; perfusing the system with a biocompatible fluid; populating the chip with the correct cell type in the correct location required for the desired experiment; selectively connecting the chip in the correct arrangement for the desired experiment; and / or metering the correct amount of culture medium or other compound into the system.
5. The biochip operating system according to claim 1, wherein: The operating system facilitates, semi-automates or automates at least one aspect of the execution of an experiment, including at least one of the following: circulating culture medium between chips as required by the experiment; controlling the flow rate of fluid movement; extracting samples, possibly at specific times or time intervals; inspecting using an analytical device at specific times or time intervals and / or separating and fixing the biochip for subsequent analysis.
6. The biochip operating system according to claim 1, wherein: The handling system further comprises a motion stage for moving the biological system on the chip board relative to the analysis device and / or the actuation device.
7. A biochip for multi-ductal tissue growth, the biochip comprising: Base; multiple interior areas; wherein the base includes the plurality of interior regions, wherein at least one of the interior regions is in permeable or semi-permeable communication with at least one other interior region; and Multiple fluid culture media.
8. The biochip according to claim 7, wherein: The plurality of interior regions are tubular conduits.
9. The biochip according to claim 7, wherein: At least two tubular conduits are arranged with inlets and outlets to allow a first fluid culture medium to flow therethrough.
10. The biochip according to claim 7, wherein: At least two tubular conduits are arranged with an inlet and an outlet different from the inlet and outlet of the first conduit to allow a second fluid culture medium that can be different from the first fluid culture medium to flow therethrough.
11. The biochip according to claim 7, wherein: At least one region is a matrix compartment outside of the conduit but inside the biochip base.
12. The biochip according to claim 7, wherein: The multiple fluid culture media are the same culture medium.
13. The biochip according to claim 7, wherein: The multiple fluid culture media are different culture media.
14. The biochip according to claim 7, wherein: The plurality of fluid culture media is a combination of fluid culture media types.
15. A biochip fluid control system, the fluid control system comprising: at least one human chip, comprising at least one organ chip system; wherein the at least one organ chip system comprises at least one conduit support docked with at least one surrounding compartment; at least one valve system that controls flow to each compartment; at least one micro-pumping mechanism capable of pumping and controlling flow to at least one compartment; at least one actuator that controls a valve located on the chip and leading to the chip; at least one actuator that controls fluid pumped to a compartment of the chip; The at least one valve system is capable of opening or closing a flow path to each compartment, and is capable of switching the flow path to each compartment.
16. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism can be at least one of pneumatically actuated, mechanically actuated, electrically actuated, and fluidly actuated.
17. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism connects at least one biochip to an operating system.
18. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism connects at least two biochips in the human chip connection plate.
19. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism controls at least two biochips in the human chip connection plate.
20. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism controls at least one inlet and outlet biochip.
21. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism connects at least one conduit to another conduit and controls the connection between the at least one conduit and the other conduit.
22. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism connects at least one substrate to another substrate.
23. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism connects the at least one conduit to the at least one substrate and controls the connection between the at least one conduit and the at least one substrate.
24. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism connects the at least one biochip to the at least one measuring device.
25. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism comprises at least one bistable valve.
26. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism comprises at least one on-off valve.
27. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism includes at least one bistable valve and at least one on-off valve.
28. The biochip fluid control system according to claim 15, wherein: The at least one bistable valve maintains the state position by means of beams, magnets or any drilled hole geometry.
29. The biochip fluid control system according to claim 15, wherein: The at least one on-off valve maintains a state position by the geometry of the bore.
30. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism controls the injection of culture medium in at least one biochip.
31. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism controls cell injection in at least one biochip.
32. The biochip fluid control system according to claim 15, wherein: The at least one valve mechanism maintains the cell culture by media infusion.
33. A human chip board, comprising: At least one 3D culture biochip; at least one microvalve; at least one microfluidic channel; at least one inlet or outlet plate port; The outlet port from one chip can be connected to another chip through the layout valve. wherein a plurality of chips can be connected in parallel, in series or in combination, and one or more chips in the human chip board can be bypassed, wherein each fluid connection can be changed independently and at any time, wherein at least one valve system connects or separates different compartments of the organ chip system and different compartments between said organ chip systems, wherein at least one inlet port and one outlet port are used to enter the microchannel and block the microchannel; wherein the at least one valve system is capable of allowing sampling, changing the model flow diagram and / or introducing or removing at least one fluid chamber, wherein the valve can be controlled in a bistable position by an actuator and a sensor and is positioned at a channel port of the chip, Wherein the valve is positioned in close proximity to the biochip and is capable of being controlled in a bistable position.
34. The human chip-plate of claim 33, further comprising at least one organ chip system, the at least one organ chip system comprising at least one conduit support docked with at least one surrounding compartment; in, At least one organ chip system includes at least one conduit support docked with at least one surrounding compartment.
35. The human body chip according to claim 33, wherein: The plates can be quickly connected from the bottom or the side where the fluids are to be exchanged.
36. The human chip board according to claim 33, wherein: The human chip plates are interchangeable, wherein the ports on the human chip will align with the fittings in the biochip, and the valves are either fixed or removable.
37. The human body chip according to claim 33, wherein: The human chip board includes interconnected built-in chips.
38. The human body chip according to claim 33, wherein: The valve may be fixed or removable.
39. The human chip board according to claim 33, wherein: The human body chip allows access to fluids from the top or the side.
40. A multi-way logic microvalve system, the microvalve system comprising: Multiple microvalves; at least one fluid path comprising at least one channel, an inlet port, and an outlet port; at least one bistable mechanism; at least one actuation mechanism; at least one structure enclosing the other elements of the microvalve, wherein the fluid path has no dead volume, wherein multiplexing between the plurality of valves reduces the amount of actuation inputs, The valves are capable of controlling the fluid within the channel so that the flow can be either hydrostatic or kinematic.
41. The microvalve system according to claim 40, wherein: At least one logic multi-way microvalve is used to control the fluid in the system.
42. The microvalve system according to claim 40, wherein: The valve is capable of directing a sample to at least one sampling port.
43. The microvalve system according to claim 40, wherein: The bistable mechanism can be a bistable beam on a flexible pipe valve.
44. The microvalve system according to claim 40, wherein: The fluid pathways are capable of connecting at least one biochip to multiple components within a human chip system.
45. The microvalve system according to claim 40, wherein: A bistable valve has two stable positions.
46. The microvalve system of claim 40, wherein: At least one channel includes a pneumatically actuated balloon.
47. The microvalve system of claim 40, wherein: The system can require power only when switching between the two states, and once actuated, the bistable beam will remain in position.
48. The microvalve system of claim 40, wherein: The microvalve can be a bistable magnetic drilled piston valve.
49. The microvalve according to claim 40, wherein The bistable mechanism can include a magnetic channel.
50. The microvalve system according to claim 40, wherein: The bistable beam of the microvalve can be mechanically actuated and squeezes the flexible tube when closed.
51. The microvalve system of claim 40, wherein: The bistable beam of the microvalve can be electromagnetically or pneumatically actuated.
Citation Information
Cited By
Brain lymphatic circulation reflux system multi-organ cascade chip model construction method and model
CN120581216A
